var title_f14_45_15056="Plexiform neurofibroma 1";
var content_f14_45_15056=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F68166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F68166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plexiform neurofibroma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Periphery of a plexiform neurofibroma from the sciatic nerve of a patient with neurofibromatosis type 1. The term plexiform implies that multiple nerve fascicles are involved by tumor, as illustrated by the arrows. H&amp;E, x400.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John E Donahue, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15056=[""].join("\n");
var outline_f14_45_15056=null;
var title_f14_45_15057="Type III endoleak after endovascular aortic repair";
var content_f14_45_15057=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F74867&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F74867&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Type III endoleak after endovascular aortic repair",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 260px; height: 359px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Persistence of blood flow into the aneurysm sac is seen (arrow). Angiography confirmed the presence of modular dissociation (type III endoleak).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15057=[""].join("\n");
var outline_f14_45_15057=null;
var title_f14_45_15058="HSV-2 lesion mimicking condyloma accuminata in HIV patient";
var content_f14_45_15058=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75196&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75196&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    HSV-2 lesion mimicking condyloma accuminata in HIV-infected patient",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDw12YOcO2c+tODOw+83502RWLnHHJpVTB5NAFiORv7x/Op42bOCxx9arRrzVlV6ZoAmUsf4iMHjmp1LFcFmz9abGue3FTrGMjg0ANG7B5OD70oR153dferMUPGMHmpTCCgGORQBXhd1fIbH41YmDspO48+hpvkDOdtWniDW5IHAoAxJwSf9YfzqvgnP7xs/Wr7RDB4PWq7gbuUPHegAt9xIVXYnPY1s2tnIASzsOOKq6NB5jsVXgd63tnIx0FAGa1m+SfMYj0zVd4GUYAZSP4s5rd8vPSmPDnqp+ooA542753SyMMc/KaaQ7EGPO31rdkslcgqPmqtLaOMgD5fUUAZyKIzh5C5PbNWleVk272VQe9SCBRnC7z2zTzC2AScj3oAaG2P8uST3zUoL5xIxIPIwaVIwMqBz6npUsUfQkgkGgCSF3JwuQM4q/GrAj5jj61HGF3j5cfSrRUYoAIy245Jx25rI1GR3mKIzD8a15m8qHKrurI2uzNIQcelAFaTeoAZyPxqtKcchyT9auSR87m+YelQuqgAqM5oAzpnkbhNw9DnGahHmbvmcg49auyxOznONopBbxk/MST60AUJCwXAZm9eagWSbdgE7fr0q7NC+4rGPxqa109pZAsj8Y7UAW9FV9hbeeRzzV8q7NkEj8altLFbWMBNxz1zU6x+maAIFRl53Nj61KPu9Wz35qVEJ7cCn+SSAVHFAFUhj/E30JqvIOuSQfrWgY+Mkc1WljwST+FAGa2/+8351C+/n5j+daEkWQc8ECqbxbh6CgCuWYjBY5+tLGGJ4J/OnCPLbVqdUKpg9aAK7bicBjj60zDAH5mP41ZZKjKfMc0AVzuyPmb86TLLzkkfWnPIi8E81UkuwuRgdaALDSNk8n86gdtqku5/OqNxdyE8YGagy7feJx70AX5LoLE5UsT9ax4LiRmO5jg+9XJl3QkqcdqpwfODxtwcUASNI3QM351C1wy8B2z9ac6sxxjb71C8JHyg5JoAR7hgT+8Y/Q1C8rgZZ2z9ac6eSPmxmsu5uC7lR1oAfd3khO1XbHsahjDuwZ2b6ZpEjK8sOTTicdzQBYLY/jYe2aYZnP8AG351BnJz2pGbNAE3nN/eb86QzMn8bfnVdnwKhZye9AE0lxISfnb86iaRsEszfnTfqaZIeKAGJIzSr8z4JHeikX/XJ9RRQB3pjxIxxkZNII++KnJzKykYAJpVxuII60ANgiBOTmrkUfzAZwD3pkQGQKtxAjgdOtAD44cHGTirMUWBjtSRDA9atqv3T2PFADEiIGRnFWliyA2Mj1pyIB16VYQDoDx6UAQC2yMYyafEu2J48AZq3ENx7cVKYg2cKMjqaAMCaBh8q4/EVny2zAkFwDXQTxbWAOcnpis65QKScN6c0ASaJGEYozA5rReF4iT1BrLsG8ojCHJPFbysrpuYZ45FAFeFlTAbjNW40DDJ+6ariEfexgHpU0cgjwjHjtQApt8n5QQfWmLCQWDL7VMs4VwDyPWr6xq68HPvQBjyWfGYxkd/WqxhG9gcnPatyRV7n7vpUEsI3AqPegDLWHzOnykdc1YjiCAbRye9SNDlmOeD2pyD5AF4AoAEi53DrVuKMHHr6U2EZU8VMpKrhRz2oArXCuWCqu0VXMG0EMwXHtV4pIuSTk1Adu3DHc3cGgDMkTB5Xr0xVWYO3ITCjuK0LiQkjYoAHY1UfcX5bA9KAKUsR4LnBHpUODnagJ9/WrcpXBHLH0qa2hdgBt2qfWgChHDJI+cbR3ro9MskSJWKc9c03S9OBO52zz2rbCeWu1QMUAUWjBbPakMGOoxmrZQDOTjNO2Erg8CgCmsQB5FO8rOSMhatEBWHcUrrjHoentQBRMW4EgZqF4OcntWh0+99yo3PBwMjPpQBk3MRJLYxVCZA2SowK3JowxJJ6dqoTIBzj5aAM+G3LPzwB1pboiGNiOcVoQIqxO5NYmtsRF8uTuoApvqRkkGwADvSPKz/ADq35VnTxbQrQ/f70qO0Q5BJ9BQBNOW5wMk1B5RAwyYY1NuHXBzSyf387j/KgCp5DfxL+dOWIjAk5BqSQq2C3UHpSqm/lsgUAMe3JjYjASqVnCTuJPy56VoS7gjBuFxWfDchI2IIxQBZk2nCgqCKqXTrGh+YEiqt1e4yVA6cmsmUzXOSoIX1zQA67uGnconJ9qjjgCjk/NViC32Lx19aSTB4BH1oArvkNgHJo+71PNSkDoCN1QuMnnrQBG3WmMcUrA9zTCPyoAjbnntSY4zUwTjPamsp9eKAIjzTGBPHFTlMjimlc96AK6qRMv1FFSqv71M+oooA9BKfvWOc8nNLg4x0NSEbZW46mnbd2CO1ACRgZBP41cjU4Uj6VAkYzxux61bhTsM0ATR8DirduvHzfWoIo+ME1ejQgBj0FAEij1qRMDBFIh/i7GpV28AHPFAD14YHg5qZJMMVXOD7cVVikG8goTj0qxGMtwxUe9ACSJHu67vrVG9jYryowfQ1qKmHIKqwNRzwEqcjpQBipGyhcMBzWxZFVjABDMeoqj5YRwQvfrV63JCgKu33oAsFMqQ3OO3pVWSNlyWAAPTNXIV2HdksT+tWmtw+3LZVvb7tAGOoKHax4PRhTZdS/s+CR5MsqjvV+e3aPI7etc34xm+z6W8T/NvHWgDjdb8U3U947W0rIhPIBrY8L+L5nuIbS9YMjnaHPUV5+4O9j70sTOjhk4I5oA95mmQ7hH94elMilDMQSPYVxGheJmeECbHnKu1iT96nNrxtpnmblj0HrQB6Hb/PtRTTplYkKOD615JL4wv1vHkibbGT92tGw8dzq3+krkfWgD0ZlfaAzFSO471G4jC5Ayxrn9N8V2VyB5jhWPYmtOfWIzgwqM0ANuVZskkDHtVR4gdpfLY71ca4jkVWLjJ6gVPZ2/mj92u4k5oAyEjczYSLr3rWtrKWXlmIxWpa2knJKgGr8UCKOBn6UAV7WFYUwBSsDuq3KhwNoqAISehz70AVypAOTxTlPmcdRVwwbl68ioSvIRF+poAhKk5UDO3vSEAHD8Yp7/JUEj5ByaAFYgkcjaKjmlDkDoue1RuXYEjGBVSeYKAEwW74oAnLrtK8Z9aqTBArbm49KqXdwq8lmzWJqWoCPJZ+vQetAHQK26IhQMHtXO+IJcOEBAxxWeNUusEq+E+tZ007z3CtITg0Aa0S+QgbG4kdTVaWMofMBJ3VaVgsYQHcx70jIYxkng9BQBUU7eQxOaSRgG4Y/SpXTYcnnPak2AfMSBmgBiKGIZsn2qdsMnAIx60qx7fnBzSEMxzn8KAIpTmFyc9K50wyMCQDtz0robzH2aQk4xxWZZrlNzghaAKMdiW+aX7g7VL5ar90AJV+TBHTC1DtBPA4FAFGUEnK8LUAjLdAMVpOmW+6Aopnlk9AMUAZrQj2z601oSVODV+SPDgBRUTg9Bg0AUGiGOOtMaMfjVuRSMjjNRkdu+KAKpXFIR61KwwcHBNMY4PI/CgCJhzmmkZHWpDTSMCgCMDEqY9RRTsfvEI9RRQB6T5R85tx79KnaIE9AOO1PIUSEoDjPOakIwCD1oAiijwcdferEaDORnikjAx71ZiUbqAHwx/Nnse5q2sRPJHFMhX5gCMjPSr6qCDkYx6UAVUVlfHRR3Ip42h8KMn2q0YmwFK4PvSGHjKR5K9xQBEChzuUq/rU0QBXgg+tRGI+Zv34PdTUqKw5CgjuaALEcZHO3P0NSeWdpLce1RRsqAYDfWpslvmL59jQBXeESNgAKBUMcWCVyc1ddt65VcDviqd9OLdQ0aMw7n0oAtwIAAO/r6Vfh2qMHkmsewu0uVBVsN/drUhdTH6uPWgBL4pb25kkIK4715j4u1AyJJhlKHgCvQdXmkS33PGGGMCvIvEcoNwUBGM5IHagDBaMY3DvWjpOlyX1xHFHgFzgE8AVBBHvYKBmu+8NWChYwu9kJG8bePzoAt6Z4Hj80XBVHW3GZYc58wexqXXfCTLsmNsba2l5jRuSB716HaXNjBAPJ04o4GNx/iqhcLea6xt/lxCOBnnFAHhuraV9mdwh3AHtWO0RU817g3h23S5e3v02ysMY61xuqeE0Ecs8V3EAGIVe5xQBwGCpyD0q7Bqd3DgrKxAqa6094mKsMn2qo8GAeOntQBvWHiDEiNOpBHU9jXo/hjWradVUSIM8jnmvGY8KpWT7vY+lLbzT28m6CRlx6GgD6Ut1GCUwwPpViKIg8jjrXhuk+P8AUbIJHIfMReOeteh+HPHmm3yqtzL5M/cMeKAOrfO/cBnFKEXyy54J7VJFc286ebbSo6jrg5pksi7dzdCaAImy2SKqzkMcoMEcGlll5IGQKoSXC7mGTmgBZztUEPlielVmyAS/AqJ7hUY5wx681WuLk7Rv6dhQBNPKygqn3ayridIjgE7qbPceYSAWVc9ay5pxkojH6kUARXl4wbCncxrFmcCY/aTvY9FxV6aQhmVCTJ/e7VWTDyYY7pB1OKAEkQ+UdygKegqvaW5lukRgcZ4qd5Pn2AGRh+VbOi2peU71/edvagCVLNYRs3Bie5prRBSFcjPv2rQa1fdtflvWmPbBVw+Nx6UAZUluY2+YhgaI7fH3sba0vs+0fOoJ7VBIpU8jkUAVhFtz0phiI5JGKnK7s7l4phT649KAM/VUHkei1nRBnjB2/IK09UG63fPAHSqFsSIVU5CjmgBuzdyRgelKyYGBkCp1HmEkA7RUcuSMdB2oAqsm5vlBC96aeu1RxUzZAIBNQnge9AEUinI21E4AHA5p8gfjZTG+QYHLdzQBXZO3U1FIAKmY+nWo2OD70AQugA96jOcdMkdanJzk96jZsfWgCDHrTSvXIp56ZOd1IcnrQBEq/vE9MiipEH7xfqKKAPTmDbimMDNSAbVwaSQHzCS3VqnkHPA4oAZFz+eKuQjJwCAaihiwCMHNXI4wME9qAJIBke4q9GDwVWqxQsAQOKsQNg4XcFFAFsbpSTIwGOnFPWMv0XAA6g0iqBtOQ2eoqULu6AgH06UAQNCvDc++aFTJxxg+9XNu35Y2yfemGAnmRefWgCowMblAahuZDEm8qCR2HerjdMRnPrx0rI1ORAP3hLdsD1oAz5NYYNkZUA8r7VWu9cklVlhj4Pr3qreh1n3xkbPSkiMsrgIg2+/SgCe0v8AvkI4OAB1rds9Vikibz28tgK5OWNYJS+4Mc5wDTZbjzZMlQPrQBp6nqskav5NwXjIOQe1ebXUrXN1I55JNdFr92Fg2JgM3WsHTrdri4VFHzE9PWgDt/BGhQThJbqN2ViNp7V6naW9tYxmK2gjjA4YVynh9bmTTILXbIkcQwWIwBW7BK1qphklVgPulhQBqThrlGjjZAqjn6VhiQ6bctJHeYyNrY61rSQ5twZpdsZGRt71iONOEM8csIEv3lm7igCS41Qrbny1WRy2BK/WpbqwtbuIecsalk3ZiPeudluVmKwLKgQEc9K1Lu3ntHiTMTKw42t1FAFK+0VrSBJQolhzww5xXN6hpERG7aPmGcr0FdtbXMYMkF0sZQjhQ560yCwVp3KxFYOqnqKAPOLnw+Db7sgZPBA61nPoc6QvIFygOM5r1eeRYEFs9qjwlu46H61k6jbxI5JjMaEYxQB5VPaSxkhwQRVcIVORwfWvSrrSIWsWdsmQn5fpWa/hxA4E3yAjIPrQBz+jeIdR0tj5EzFT2Y5FdxoXjsTosOocN/eFcfqOivBzGN4PcVkPbSqfukY70Ae0Nqkc21UkwG6c1HNdx7vLEgzXktrqt1A65cnbWwdW83EhbLemaAO2muFiz0dzwADVRpAx3TMVK87QazIdRiaJfJTfN65qZmQ/Ny8x7dcUAE8pkGCSiD9aqMr3C4VvLVe5HWpXAZ97lsjotSrH5o8xy4IHEYHWgCgoJj2opyTyTV3StLkvRgYQd2xWlbaVNc7ZJiUTsm3mult7KNIkRPk46UAYdroiImwbRjktir1vaJEgWMAH1xWnJCdu3OMVC0DEDaelAFRogOf4qqzQ8FsAv6mtNgWUcciq04yoO3JoAw7iOTPzH5vTNQeWpXLZ3j3rVliVcOUO7tVOdATuKlT6CgCi20gq2VxUDcnqcDtVqZMnd3qA/NyOMUAZersTBg9zVWMbtq54q3rSllTBAFR2cW5hyABQABcDC8L3qORcHOSQKutGGJAPFV5gQSimgCk43Px0qKQAHFWpAQNq/iaqOuX68UAQuSeAcVCwxnuTViRMHg5qFk4zk5oArPxwOtQnI571ZZAozzzULjHSgCE564NMb171KcKOvJqNx3A5oAiOSOetNwe/WnMGJpCOMmgAT/Wpn1FFEYJkT6iigD1+OJRK/8QJwMinmM7tuOlPB8xto6Ke9PUY5FACoh4wKtxw9D19abCvPXg1ZjIXcuKAHxJtAyOKmC5JA6HpxTY1V/u9QOalVipAU5PpQArKq8MMH2NPRCF+ViBTWkVlww59aUEFSAfzoAnzs+ZAHNRzlgpkfcqjnApFmVU2hdze1RzgyRlZHK+1AGVdao0Z+TZ5bZznrWOl8tzM0bp16YqXVoQkTCVQU7EcVlZhLBowybRnIH60ASTxgSPJu+UdVPUVAZUUg2zsSPvL2okkQorSSF2PbFVnfc5ZF29uKAJpPJk5wVk7gdKiSIyHdlQB696A5gYtGwYkYOaincQ27yMB0JwDQBzmuTia7YIMAcVpeEowdQiJBZg2QKwWO6Ut611HhCGd58xDjvmgD1iJpzEPNxGpH3V/rTGjZT8u2Re27tTNMuPJtXVi0knQh+n50+W9MBNtchFRxwy80AN1i8keBVXZlFydvSudvLoqqruRi3IUDmrl/LtiMNoN0fQyYrIa3lmYKFXdjh8UAOiaeUMscMaDvuFFzFKAjSTFmHGORinLayRZBlcPjOc0y5kmVRulDjr0oA27OaB9ASzlsxPMsgfzEHz4zyAetTX0YaQjRZpFtuCYJThlPcc1l2GqIgzNGiSAYV04NRS38k9zIsxkmkb7si9cUAdB9ofe0cdsVZFzIpOfxqg80Vw6bmB5wUbjFM0qwurnznhvBGQucOeWFNa1kupz8oViMEDjJ9aALFrEp85ADjqnPaq3kKxEUg6dz0q/aWRijkjAb7WhyAO4pXR1tfMMLtzg4HINAGNd2JVW24x2+lY1xpu9mUhSSOgrp2u443Czox9AO4qu5825YrHhcfL7CgDiNQ8MTwoHUcPzVB9DvYYBP5beVnGa9MHkSw+RIWcn7p9KfJbPtEaDAwBtPRqAPOdNUpMARt9a7GxsYZkBtgWY/eOamn0uK5ZkMYSQHBCjpRp1tJpl4sJwIXOCwoAuw6MqsHRS7Me56VtWmjRW7CQ4ZyOlalvbpHEDEOPU0svBHlL+NAFIxEPnHz+lGzncT8wqVcoS5be3T6UoYRgl8EGgCtPhhljUbqQQwIx3p0oG/J59BTWGMMeR6elAFeVfMb90MDuah8pVOF5PrVx2BGEHFVpNobhuvegCvKAvJOcVSuI1xvycntVyVUBwXJqE/L1bNAGVNDtG8Hj3qmVIbcMYrWuVf5mIGys/uNwAU+lAGHrQy8QXGCat2sYEaqAD6k1Bqa5u4wBwKsnKoBGo96AGzPgbU2+5qjIpJIBHualkcjIwOe9Q78/KoBPrQBFJxwDk1Vk+U/Mee9WJCRkAD61VZzjjBJoAjbHTvUZUg55pZGKjGfmNQuWUfeyxoAY44yxz7VA5A5qQswPJ61GeD15oAiIxz1NMOQCe9Sn35NRsMc0AQt16mjryTTmI3DFBFACxjMifUUUqcSJz3FFAHr3lusjFu5zU0ADE8c0u0liW5OcVLEhx0+btQBLF/cyN1ShTg8E+tCA8HbyPzqcLtf5R17+lADCVAJVyp7gdqmRt23b82B24qHYFY+aRg1NHGDnCnHbFAB8qkMDjPWnBjt3bgR0wajLxryqnd6GkY5QMcYz2oAk34BwMH1pGdtoY8+1QlyWwN2PpSCQI/XPtQBl6nKLtWiMbLzjPasprRLcHc2SRjNdHLKhbDLsHcmsLUbq2cssS7wOCaAMe4RUZtrI5XnbUBmDpyNnqKkubcgF44zn1FUm3EAsSMdqAHllZiqsDVLWZTFbBR/F1qyuQcLgEmsfXmJmCbs4oApQJvkGPWvRvB+mcDzXaNcZyK4rQ7cyzDjj6V6hoqBIPvLGUXjd3oAuTyKk3lxzMVxjPc1FJGNmZzlD3PUVDbzKWMsysWDcYHQ1auJ45oyXALHpQBUkG2Pyrc743OCvv61JJHcQWwjdVAI+Ujk1BENikocnPAFXLS0urphsjO3uScYoAzxBNPGvmMQPbrTXtYzE4jVmkX1PWuptdOZUEMhTB5DetY+rRiOd0REVgfvA0Ac60DgndGwAq/YwMzJJG2HpUmmllKsxf8MVoRBYyWRSOPSgBrXLQTRxrHtYAhz2NWJLq3mtDcCVopj8oXHDY9DWcRNcDJVjjuabsmePypSViByAB0oAntNUliu1lc53fLu64Nak93JbyLKsqlW5Pp+VY91ZGzKrbOZsrvY4zio474xuq4B9cjNAEuq3DSuz7EODncvaqcbzOS0Zbb0PNJeRhY22sSG547U/T2CqRIDyuV+tAF+wjKMhDAAH+KrUsjLczIh83A4K9qrKkixq78sWx5Yq5EyWwOxPmYckigCGwUxXEst1JjPP1q/diCWIMiM38XTvUOnwiS5aWZN+R8qmtZIwNo2YHTHpQBDo2pLd27RzDy3Vsbc44q/K5zsTgetUkiiiufmVVD8Ma0UtGIMbMCAMhvUUAVonCZ4znjNEvKZb8KteWiEIuNp/iqOXMR42saAM0ja4LHJpMspO5cg+9TbHeQl1BPagY58xSDQBVkQA4fcimoJSoBVWJq1IrN1yqiq0igE4b9KAKkhC4AKkmoJcngEN7CrTLjK5BJquYCoOTzQBTmV1BEpyp7VnPkOUYYTqK1ZFUph8lqolELN2IoAwLhmm1MD+EDAFTyA/dTJXHOKhjiaW9lfkHoOKuGLYNqMTnqaAM6aJt3AJqOTCLwvzVekjYDaCTnrVGVeTjP1oAqSDGc9TUD+gHNWpFJGFBJqu6kdvmoAgkOGAPWo3OOB1qVwccD5qYybRzjcaAKzHA6ZJqIkp1GSfWp2Ug5NROOx+8ec0AQtnvj8KjY7e+TUjYB9aawA+tAEeMcnrR93nrSnAOOtCggZPegATmRD2yKKRB+9U9twooA9yWMAnAqykXGRwfWoQQH59asxkg8FTnse9AD0QL8rKOe9NYFCQDg+tODDpJx6VH5hYsqtkdtwoAccIVMhDU4N/d3KD3qFyApLbTjtnvRuVo8yMyYHTFACbwCQDn61GxAJZhz14NVnmDD5SM+9QOSz/3jjsaALEk7cYLLn1qIyMzHHzGoyr5G9in8qYs2ZAkYGT1Y9KAH3cZuI9pLoeny1lCyNuCzOCPcVoPLhmUbnYdx0qC8u0hiLSnoOhFAGNctvY+XIFUdVzVADBJPT0qxNc/aHJMSBezL1qtwUGOuaAHkoRkKeK524R5bpyV4JrZusx27sTnPGM4pmkWclzIo5I70Abfha1RVCvCA/Xf7V1skSyxNhlCr+ZqjZW0ixhFKKOmcVJcyJDAI8ky56g8UATwlSyrlNoPT1qa7jNtc42qQw9cg1lwQOwdw3PU1bsl81xvz1/OgCxaWsxlYoBuHzAV0FhCJo8lvnPXBxVbTpYNPVmUNIzHGMdqna6t3ZjBujz6igDQaCMoy8Bk6YrEvLUK7sIg5Izk1ppIixjLhg3TmmylTER3I4BoAyLi2ISOV4lVm4CqOasaNYODLLcgMh4VccCr1vsku4p36Iu0pU/nfu5dpwCTQBgeIbqO3fy7dVAUZJX1qhpV1KjNL5RkVhggjim6isk168UC72J6etbiW0iwxROgi2qBtU9aAH6eklvDJMRG3mAgIeo9qwJ7Iz3BIg8rHIOODXTQ2xZh/DUtzAEGwk5HSgDjLu1uogC0RWNupIpNOjIlIlB3KOM108xYrhuV9DWc9sk9xiRhGCp2k9KAJ7MJdgLyzjlAvrUghMsMu4gSBsbT14rKti8bKyMUkVuCDV9zPM+Ech2+83c0AWraaJEDl18xflCr1zV0s0Vv8w+ZuSO4rIS2+zFRtG/qfetIThwAoB45zQBC06/Z5C/3s4GetN0+/kuJhblyGC4/CnzBGl3gZAIHsKZPC0epQOmAH+U4HFAG8wCQiLG4gZyaqTbtuFVS1XJHwFQEbsYyapTZUbEG5j1INADI4gUO4/P6CmMmRuLcjtUgXylDKT5nfFRk78s5OB2FAEZjLJuBwoqs6FxwRge3JqzMRnIkwnpVaRyASjDFAFaTrhFwfWoZNsafMQWNTs28cEA/WqzKvVVyfWgCsyKwO4bTWfdRgEsvQda0pEwpZyfpWZcMY1lZCTxwDQBkW/wA0r7T1arcihBsHNRWTGPg4LMck46VKZPnODnPU0AVpVCEBeSaqSjb0G5v5VanfBwD8xqtI5ThPmY9/SgCqzBAcfeqtKhyCOpqaUsTjGTUDErkDOfWgCCRD+Peo2HYLkjvUknPQc1G4A7c0AVmB79fSomAX61O5x0xuqu7bSRwSe/pQBFzzwOajOckcU8njA4puAeF5NACKoGc4zSkDFP6DHGfemNjvQA1B+8Un1FFCECRc+oooA9zjVSzbjg54qRiAmSNxHTHWnPECxbIqJ/kfcqcnjIoAc+BGHdtp9KiE7MQF27fWmS5yxkJz2FR/NIMjAUd6AFklTJypY55I60yZ8jMkhUDoKjmljiwsUbFu5Hc1BcMoQySSFT/dxQBJ5pkVViCEA5yaiJC5CqS567TTAWkz5bIFA65xTE+QhIIixbksD0oAdt2EvLI+B/Ce9LFulwdyJGOenOKZ5ix53FmcnAUjNSjlGaR1UDjZigBNuV/cJuJP3gazXtLgtJvm3I3G1lzWy0RmtcxxeWoH31ODWRayrZTrHveYOeuc4oAz5bRrXzA6goeKzxjzSApAxXVakQkRaVl55UEVjqgnO4hQf7uKAMlrZ7hljQE85Jrp/DVukLPFIAT2zUVla7ZxgFc8cVcaNo7ng4I7igDd8t1i+YKfSs24h2sCxDDOeOoqzCXZSrSZzV+2s0RGkuHAJHy8d6AMZFw2V6HrVqCKSJ90fQ+tD3DO6v5ChUbGTV6eZniGEUP1OOKAIWvJQqI6AIOaqJqTnfDGgLE5qNZZpJ/LbCI3BJqW3jt7aNi+DIWxuHXFAFhlkMAkaYbB1HcVYtJbi6Cty0aDj1qhPq1qkZtjGN2c7+59jU9jcOqAxj5T2FAHR2rDaw2DJHHtVV3ZYJQvNJFJthBfKnHepNPZJ9MuJV+b5tooAh0O0C3H2h+STitq+EErqY8hu5qpZjZEvGcDFXbhFSyDKP3hNAEMcbq2XOVqG6uPNnAAyoHarNmJbj5WG1QOtR6fZs163ZM8kigBtpZmRiJsopHBqJ7FTIUfBTsTXY6TpIvDJEZ0TaCVJ71jXFk7h06yIeQPSgDn7nTo2h/drtdehHeqtjFKx3suGU4xXTLaSqm2RcDHBNZmoWxyZIeJF7DvQBSvATJHzyeKkhiWKME85qibgTPtKEyK2SPSrHmiJxlhtYZHNAD2wI5AB2zT/uLE/wB4KQQKjRjKxyCq0sh2jjJGDxQBtzSO6Fwq4IzxVFg2MRr16mnWEkk9mNvGDg5prh8kKOPXNACBRDyAWY9ajbCAkvgt2qZcoM/Mc9zUEpKN8w3Z7+lAFO4jydxI2jtUMx4z8oX0q27HcNwBz2qJ0ZhlkUD60AUtzsMKigVEyle3FWpVJUiNPxzVOZW4AyKAI32qO5zWfdNhHLLnI4q8EYHavPvVDUxthcSEFu1AGPBIxJGOT3qV5Vj+UfiajgBKbVAz3NLMhDBVxk96AK80yg4XLepqq2EX5Sd3vVh12cAcnvUTrwMHk+1AFVyUxtOSfaoZQAcksWPWrMylcjdkmqrjBO3JNAEEjhfugk1ETk8ZqSQBTxkk1G429O9AEEqfxc5qs/B6cmp5FJPrmoHTnigBnUdKRSNuFHPrS7MnANSLHzhR9aAIyew/Omt6VKygfWoJfXvQBGD+9T6iimD/AFiDvkUUAfQjSH5s7cVVd1HCZqOW43bt+0jceh5qpLc8HaCB6igCeaYR4y+456NULSO+c4CZqq10ikfNvP0qOSVmUGZgRnIAOKALJmVfli3E9zVeeZUXEjhmJ4BFVzM8hcRKQBxuzxVYzLE6opLyeuM0AXM71d5Sm09AOKkj64hi2qBgsDVQfu9rzurMx+5irsEEszNJJtjj7KDg0AOjVEZRGJGkPJPUVZcRQx7riVXLHoRUkQIXZbow45brUzWMbIBnzJMZwRQBj3NzKGaPZtgI4IPX6VThji84RJGVH99jyK0VsbmcSC9YIi5KjNZ8kzyZXyiqocBgOTQBLqFkyKoacO+Mrk0y1tcj95hmHPHah78yIFMeWTjce9NV1WNmVgSeNooAt20C5b5woPIPWlZ4y0gLfMo4PrUWn5RgSOOpB5zUBZQ0rFMEnIoA3tPdViDlA5x0qy8+5GGCq9QrGsKzuGEJZCQ+MUjSO2C7HP1oAtSKqy53nB5xnipxK7HeSB+PasmRwJwXYEdOD1rVs0SZVLAhDQBaijSWLzZGUqcgYPIPvWa+oRWNz9wOR68it+4tbaTTBbwRLvzkyAHdWGuhWqzj7TO+c8qRyKANLwyVvI7oT28MkUx+8y5K/StxIYLSLaEUDtxWeZI7KFY7JegyD0zWDqEmrahIfKWQZ6IBkmgCbX9ZjXdbwHMjHArc8MIbbTGgnBBb5wT61yPh3RmbVs3nDJ82DzzXeOodc4247UAOsHaTzgRjYasec8kAduims6GVlkaNTyf1q3bKyu8Tng9qANSa982zRkRIz0+XvTdIcz6jFazOIY5Dy57Uy7EVvbw7RnHNXRDFcomVAcjIIoA1I7AedNF9o2qh+V1/iqvdRy2rx+YuATjPQmrLyvDZoEjKunQ+tYOoalc304e9kbenCigDU1e7eaJI9gG3oVFY5tSfmzknkVEbydnG3OO9a2noFYO5BB5oA5vVNKO/7RH8rdG96xZrURXQYMTH6eldxrMascocKe1cNrjz2c+7YTA3GfSgDTtwwUHOQehqSUk4PAqjZSyC2VwMp9elWHZyoJ7+lAFnSGZo5gzfKGzirRO+XbtAiHU1S0Z0W9ZGx8w4B71qy43EGMrHmgBjNGqlYydp9aqMQhwzBmPSppMZO3JUe1UnbLkH+VAA+AcyFSx6Cq0pBGXzjPGKfJwORlu1QspI/eD8KAIymSSAwX2NV5EGcENirBjz944FMYkAjt6mgCuV2dOF96ztWGYCMKxNarSZBHX04rG1MYhbn5qAKUKq0e3hcVE4xkL/AN9YqSBiYxtIwD1I4oml3jAwAOtAFYrn5d4zVeUGNsZz6k1KWB+WM8+pFQygfc389z6UAVJCQx4+p9KruMnJ4qxI+CURiV7kioHc5IH50AVnAU8ZJqFjxwD+NTzHHC5z61UkB6c47mgBknT5c+5qthifl6dzVh4wDwDimIgJPHFACxQE9+PWnSYT5V607BCjacKKrzON2Ac0ARStzVeRh2p0rYBxiqsrDAx170ALu/erjHUUVCG/eL9RRQB7PPIM5lHGc4Bqu1w7ZC5RD3NRSjZIzzMrnPAqtcu7Fd7mNOuO9AEslxtcrG258d6gkCYH2iRWbrsB6U1ZWZW8nK5/iYUqYD4ZfMf+9toAcis6Ev8AJH0wG5NPhWZnItkdUHG9hmn7Snlmd4mJ5CLWjb28svzSDy4j0CnrQBFHAIWXeTLL2yM4rRgh+VXugvPIUcU+1jZWbyVYA8biM1oRwxoMykTOOmRjFAEFvbOcsUMcXbB5q9CEj3eWrs2OCwp6QB0VpBgdQFNTHzVhPkjaM4wR1oAwLmBLidjNPtkHRO5rPv8Az4/k5jVf4iOtXvEFs+5buBQZl6jPWsy7la4KyNJhdvMYNAGeVZ8EA8nJJHWrEEUblVjGecnPaqssqyMY0DKF4HtV+0ugioZQnydCKALVwgtY13HluBgVTdBtAY/jVlJYrqZZhIzeqMMBfpViO3W7l2MdoPfHSgCpbBBjjIIxU87RmJSihWj6EDk1dSzWKN42UMQeGxyKu6da2sjZuVcKBxtHU+9AGfYWMMcC3VxFm4ZsqCOPxFW57j55JAsUYxkLGMD8qnuC7yHe22P+EY7VzWql9rCNmye1AGpDrM4QiN0CMfm9TW1bm1khWWSTFy/3t3p61x+haSt+f387wovcdzWxHYaejBb25nkGSODyooAv3Jt/PC20okJHPPAq9pl+thazu8CtcuNqSE/cHtWNHaoi/wCjgtEDw2KhvbzkJjgcY6YoAs6YzPqJkB56k+tbFxcbFyfyrnNGuFOpKgbgqa6kxKwyQDmgClZSea8rBCMdDWm06fJIfvng0lmsS7iB8m7BGKfOka3TeWmUI4B9aAJHlEigMMinCV4kzHwKqEPtJwAfanQx3DJn+HNAG/p+pSXNuIrlsFPusOtaNho9nqCNNdyCNwcAetcrD5ok+7g+1a0Ek+FUtjFAGxrem2VvLstDlQnUetZcSSRxZ6oKfeMyY+fJI5qtLcMLfYzYoAguHDPjpWJ4hiW4ttvB9a0Z5QBnqazL0FLeR244oAx7K4UR+S33F6gd6vQsegOV965qyucXhVhwScV08G1l4OcUACErqEJUDOea3nWR5CW5WsHaBKhHY/rXVWts5QPMD6AA0AZkpkVCoUhapyPu4B+YV011pryxA4wvqKyLnSJV4TlfUigDLLFSNw3H1qGYEvuAz6A1bnVoTs2lj61EsqZxtGaAKLn/AJ7KR9KhYhxgbgK13jR/mYDioJIFJLYwB2oAzGUsh+Zhj2rG1jeIiMAk8V0E6fK2GP41gap8+QrDigCjEZHhCD5E7014wyEBgADzUwUsoIbCgcjHWmTAS8K21R2xQBXfDKAjAAVVZVZiu7p3NWnX5chtqj261XYiQEK20D2oAqTFTlFOFHeqkhwpUZ+tW5NrEgMQB3A61WkK7SBuCj2oAqvnkfMB61CqkepFTsNw7gfzphXIOcgUAQOPqBSpGScnhKkEanPmA47CmzNhcFfl7UAQTMAMKPlqhLIBn0qaUnnrt+tVJD1BHFAEcjk1Xc4qRjgcVEQSTnpQA2M5kQ+4oqWFcSIB6iigD1eVxGzsoDyEnrVRk3Sb5sZ6gZqzMcs4jIzk8kVErIm4fLJKenHSgARXkUb8omeAO9WIVeRikQKj+9ipLaFUQSXWC3UKGrQtVeTB/wBXHnpQA63t47U5yJpCP4h0q5GGk2tcIAOyimw7gx2EE+pHSpwoVsyMHb0zQBaWRsAKCietPTO75JFdvUjpUCpu5bKr6ZqWIEjEZAH+0KALap0MnJ9FqZEeTlm2RjoGqorCM8De3sak8wkbpC2B0WgCtqUxSPNuiyEd8VyN/IHctLEiPnog5NdtJ5lxDsCqiMOpHNcT4htDazRqoDD+8KAMtyvmEjIHoetR/assQFA7YqSEoGOQ2c96iaBvtKkjCk5zQBds0ml+VcBevFdDp5ktlVZ1yn94dqbpUKKilMEkfnWyoieMggZ7igBqg7vM+8DR9wMhIVW5GaqW1x9lvGhkJ2Hlc1Pfy+Ym5SNmM5oApXVywUqxyR0NV7KxlubhWKZizkk1JBF9pmQKCQDkmu3h1NYLJLeS3gdE6Fl5oA5XXbqK2WNLeIxMq4I7E+tc4Z8gzTEtk8itfxVdJLdZ4APYDgVzF3EBESZMg9BnpQBoPr7WsTLEcKOQKzP7TFzIWdwO5zWBdO5Yrnd70sDMcb0/GgDqNFv4zcyYIEi/d969B0y5W6t1ZcE146sTtIGgOGHpXUeFdXuYLj7NMMhumKAPSSh+ySEdzmoYmkCZYZA6mtTT4/MsQZVxlc81mhnSc7Rx0oAc2WQshyKtI3l2+/ccnsaqi4yxQDHNOmkBG1wRQBYguflJOMmrSTsRlR+NYZyrHB47VPFc7F5JzQBpTXDeWSxyKgUtLgkcVnmQyPgHj0povzA+zPtQBoPFxk9qxdULzEqT8oHKir9zqMf2U5bmse2uFAeeRtx5wKAORumZLs+UCoV+4rp9PmZ49zkb/UdK53WJh50mOhOal0u5b5dxOzuaAOmMxV12nK+vrW0niJYMCY4A4AJ5NcvcS/LhPu1UnmhBEUil2I64zigDv4PEO5eWIQ9s9atR6ykqAMMKPXrXncNoBhhK0rfwqRgCphDcZAlkCkdAGxQB6Gbm1nQBdgx1yKyb+xglJEGGJrlGOoJ959voM5zToNVvoeQACO5oAvXVlJDwu7P1qqlyYX2zSEe1Sxa75p8uYLuHUii7W2uF3IwL+x5oAsjyriPcrjA7Vz2rKiqWCKPX3pxEsUmWm2r6daoX3710wxA+nWgA2Fot5+UY4FROAw37+g9KllIiAPmFzjpVOdnPzknH90UARyhn5wQo/Wqko83nkY6YFTvITyxcegqvLJkZZmJHQdKAIGHB3lto/WqsmXXkFQO3rTptznczEnsuajkLDG8ZbHHNAEDk5w+QfSm54G6nO3dwMjpzULvzyMn+VAA8gySwqvO4P3unYU2Zucd/rVWRj0br7dqAGyuB1I+lVnbk5x+FK/XGfxpp6Y7UAMK0g4HNPznrTSaABD+8XA7iikRj5i/UUUAepzqzlgjFV3HnFMiyCwiwzep4NWJkLOSxMaAn5T3oiQzJhDsT+8RigCSPZFIC6LK+OnpWpbq3ytOCi9gKqW4jiO2BFmk4+Y1fiiK/PPyeyg0AP89pFxGCEHdhUg5bKqpI6HNOVWcDDsiejLUkWxfliVGPc5xigBNgL7pCR7L0qWNPMOTKFUUDyUyXUu/seKcSSAz4RR/DjJNADkYAhIQGYnkinhGDkuxz6UkbBj8ioox9KkSRVBEce5j3BoAgvZ2T5jIoUD+Liua1LVY7oyRxRD5BjcTVrVnkWQi7kwp+6AK5i7Q+aTnBJ6etAE0ID/MTk+1bb2JltEYYDgVj2hYsqhQoJ7d67KzhBgAJxxQBh6c0lvMR6djWrHMGcMWw3vS31huXdjDDoR3qtDayhRvG5elACXq+fPGiZ35zWhFEPJIbGSMEetOt7B41DFcE9O5plxCwyVYg0ARxn7NzHgE1Hdam4+/wv6U0RuUKbtwPJ4qGW2eQFT09+9AEWn6Z/bN9++kEcKjJbv8AhWbrGkNBI65LgH5dvQit+OKWK32QEDuRisq9a5D7WRmP50AYEds2Cph5q7BZAJgxZ9R2FbFhA8o+aFy2fSty20hnj2yMY169OaAOONgQdsUZUsa1rPSGstlyFLFCCxrpLfSoYmDZLN6mrssRFtIgXgjGBQBet74TQDZ90rWfJMwLKBn6VTspGs5FU5CMOM9qh1W7EQZ4HwcdjQBoW7BpENXbt2f5iOgrmtC1aMsIrrO48hsdK6ObJXepyOuKAKoWSR+F59KfeR4CEKd2OQKqPJLMTs3Aj+6ansxcLktlvY0AMiQs392nSWsUQMsj9u9RTXJSXDIye+KJZIJreQu6nAyATQBh6lch3KwjgcE1mXF8tvA3J3VpXc8S23ACkcE+tchqMwdiei+tAEc115hd3OSa19JcPCFHUiuPvLjaQi8g11Hh1hsjJ54oA3s4jAOWPSodPsp21CRpOIifyq9BHudmYYX+VWGdIVa4WfcE6jHWgDWhtxHEAFwmOG681E1siqTgvIf4jSWsglg3yZRT0GetWGKhcKcD1NAFFw6rhsM3vVV42J+bj0xV+Q4ICfMx7mq8sZJ5PPtQBn3MBdfQ1nCxkVz5DlG9Tnmtx4toG/n3BqOVA/IfZ7GgDNVJISWmbc3bHNRSN5kgJOOOw6VblDKjbTuY9zXP3zzxTlgd/rg8CgC3Mojc7SzsfSqryOvI3FqW0uDKeW579qmnRFAaL5vbNAGXP5jnoxNV5E2g5Ul/rV+SVF5XcT3qnJJvz5S49c9aAKj4DHjLfWq8hABzguffpVhyNpKDkdTVZwCDtAB7mgCuSueMF6id85C/e9anZAUOOD6+tQGE47qPTHWgCu4yuOB7mq0g4I/XFWZhj72R6CqsoZz8xzQBD6bvyppIB6VI2OgHSoyM4oAYWzUZ6809j+dMOTQA6MjzE+oopif61M9ciigD1xlTzmeVn3ZPyilQvKV3uyRL2NRu4V2VFLtk5NMCPI/z5GO2aANKCR5SRAgRB/Ewq7CVUnZiV8c4rOhRtq5k2oOcA1ZimBBWKPAzgv0oA0mdNoaeRgR/COlOQtKBsKxp6txmqCEByQNx9zmp97CMtMx29gKALsexGCxhXz1INSYCMd24ueg64qhHK7quxQi+vSp4pvlHkq24nls5xQBoDkHzioX3HJoQZ/1e0KKqb1+8ZGZ84xirC5GWmdAnpjmgDI8QPHEVGJJJSODtyBXMSq2RLM+58427cV3+PMHyQoif3ieTXKa1aqLg+TKzOeoxx+dAFKwdpLpPlwAa7a1cNGN3QVxmkErc7Org9a6iJiq/eFAFx3EjDjiiNWkk5xgdqrJ874VuvFadrbbVzvDUAPRCenFMki59e+TU6A+lPcLt5oAx5rZi2UyvsKRbd8fNz9a1No68U0le/SgCiYGwDnFUriJgwZZMn0NbDgMpGeKqJCGmxjIoAtaSMoCwG6tCU4PAqvBCI0z3qdXC9eRQA+KIsckVZKqY2BwKhFwAOwFQNOGJwwx3oApaqjNbFVHToa5O5uE5SSNt/TNdhczIOCcj0rl9djLqzRDBHQgUAYwZocyKxDZ6GtC1125UhQ+5RxzXI3uqXUO6OVRIAe9Zy6tNG4aJAvqPWgD1vT9Vi8plYbX6g1r2F5FMjsX+YCvKrHXBLGN5CP1xWrb6q5y2cA+hoA9FfyZY8u6ke9YmqwwAGSEAEelcvPrLAKcnnoM1FPrUhUKRhT70AQ6vcspf5vlrmby83AFzhB2HerfiHUo5MhBtHoK5h5TKx5NAFvebi5BHTPSu58NW52gk1xWlR75lHWvR9EUIEBAGaANtE/cnnB71jhvIvmCq0iseVrUuZNoyeB6Vk2Uha7eRlEUa9+5oA6eJovLXLEE8BcdKJiIsBmJ9AKgtJop0DQyLt7k/0qdWCg+U3mDuT2oAhZ3c/MzBPyqNyQSFU/U0+a4KnDfOD3x0quyFhmWTIPQA4oAjkn+YgK2QOfSoXMchAc/N6A053b7kmUTt701FDsREmPcigBk5At2xkDpWBt3TMTwvp3Nb17KkcPdnHYViRSK6FkOXzySelAFaW0QgsHK+wpElKKB8qoOzdTU8uzqr7n7jNU50QHdvLP6A9KAHyTRuBjauPbNVpCrAsHCgei1E7beQTu+vSq7TFidmS36UAPZgRuLEAdsVXkJb7h2+2KYxZmOOWPXngVEzbmO1wWHU9qAByx69R2zVeQgn7x3D3pXYHO3APc4qGRsDpgeuOTQBFLjd1Bb1qFj7H8qe5yOOtQs3ODwaAGMRnpg1ExGTnrSs2cjODUbH8aAEODTT0pSe1MJoAWP/AFin3FFIhzIv1FFAHrBw7OiMVG45bbipYI1BKq25vWo5HwTuOwZPANJFKOQuPqRQBfWOPgN29DQGldggOyMfrUCSxj5YyGb16VKXB4Zs4GcA0ATI6g7YghbuSaezLEdzlnc8BVNVYlI53+WmckHkmrMAQ4MS8k/ePAoAsCR/vSDC4+6R1qdZxtASNVXqSOKrDbuOSZD2weBUglTJMjNgcbVXNAFlHyMQqQO7Zp6EqdxcyMfXkUzerrnhF6Y6VZt1GwCFFVepbdQAyQRzIfPbOTgKoxWXfWNzMWigh8mADh89frXQWyB2CW4eRyeWIyBVi4jSKEi4k8xic7QKAOG0+0a2uyrMSwHPvXQLH7Gs6OUT6nOQhXaQAua2kwRh+B6UALFGo6Oa0If3YGGzWaMBsLz71ai3D7zDAoA0l5PA/Go50c9KhjkbGAcVaj27DuOfXmgCsA2QCOKZcoTwoxWgpUDnioZJ4cnoxoAqwwMY8ZB+tTQ2pQkqBmkN1Go/wqZLiPGS2AKAJERyMY5FRvExPWorjU7eEY8znpxUH9rRHoTQBK1u75BJ/CnLbeWvJJJ61CNT9F4qvNqZ5B4B6UAWmgBbgZNQX0avA67QKppqB3ZLc9DTUmYyvnndxQBxniTTOSy9a464gZCcg16tfW5kU7l3e9c3eaVubO2gDhlZkbgGrsGqTxDGFYdq1LvSto4wKx7i2MbYoAmfUxIv72LLduapzXkzn5WKr6A1GwxnNMYdMnFAEbMS2W+Y+poAywx3pWA7VPaRF5FAGaANnQbZiwbaCa7ezjYouW21iaLb+WoP8q6e2jx9wc/SgAlR9u0sSarW9tvmZmTfMOiA43VrpGHZVcDGR3rcXT1i3MI1jBP3jQBg28MwZHaPycf8sMZzVuRsKchI48crjBq8yBSQq7G/56uuRVUCMyN5eJZR1w2B+tAFN5GCfuRiH1ZqgeQ5AjDnPO/qBV2VIslvLkZ+8YHFVZkCjIbEfePHNAFR3CuA6tKccErgCo5ZIpF2zFYz2ANWwGIIUqsPueaSOxR8LsDL1DMc0AZGqKVtsxHZzg571iNuVMLGcj171t+IAIysan94PTpisyN94xgI/wDeYUAUWV2P3NnrkU0xnaSDtHcdzVqRQ5YhwWB5JqnJIoz5Q+cdSaAK7qx6DaP1NQuAF3AlfbFPkkEuSEIcHkk9ajKNIcqu0+poAhc7h1H0FRStnAU7WHap2VQTgqD3JHWq8i5BIG0+45NAEDuOjffHpULuDng7/U9qlk9WyG9Kgkbf256CgCGTJPvUbnsalOcf7XrUDEscHGfWgCJiTTG9+tPxzz1qNhzQAjE4qMnjpTzTW60AJGT5ifUUUJjzU7ciigD06RibggZlYHvUoyB++YBj2BpTDNJI3krtTnLd6mjsyGAjDO3cntQAyN32khNijuTk1IkibmCIxc9XI6VPFp7swLkOQeg6CtGLTS0f7w7Uz0XvQBRiZA4AQSPjgZ4zV1YjhTO5TAztQ5zV2O1G0JBGQOm4ircdhDGf3aF5j1PpQBnxQO6AoiRRHuy8mrEMOQRbpu9WzitVbIvgzlsDoi1oRWG9RkBIcdO5oAw4rdsEHfI+eAoyBWjBpruA1wcJ/dxg1t2On7flgjCL3PWtS1soFbMgZ5D0BHSgDItNOaVtqr5UQH3geauCwjjikW1B3gcu4zmtxLYOB5pC47DilvYhFZStjZGqE896APDlu/8Aid3gbBYPg4rcjm3ICT1rg47xX1q8deFaZsfnXSWs5Kru4HtQBsqQTnIxTjKf73FUdwAGD2pRNmgC/HchT8wOPWp4b4E4UYFZjuSmeMU2KbYRv5+lAG68jyDJcAfWs8rmY9T70w3qDIVVwPWozfB+AQKANKNFRS2cmoJ2lcfIQo9z1qpnfg+acegqVYQsZOd3pk0AQS25dvnI/ColIhJA21Y8kE5Mu2l2QRjI+c/SgCFJByCDSOUApJZugUCoCQxO40AMl+8Ngxk5zV6xhaQjc3zCs+d1x+7qe1uWjIbmgDXa3AXDZNQT26Fc7RmlTUd4wR+lTBlcbtwB70AYV3ZhtwCjmuZ1TTThhgV3M6L3cHPpWdPAHzgZzQB5rdWbIcYAqk0e04Irs9Rs8swC1hzWTK2FXigDGwM4IIFamlQhpQcd6RLQs/I5zW5plmQwGPegDY0yDoAcCt+3DAAE/lWXbR7MZPFa9t8uCOaAJUGZVXGee9dHAv7tVvFDn+EA9PrXNlh5ylztAOc10FhKI4P3AZw3V2NAFhljIAuTgZ+VVbmq9whmBVlMSA/KAByKk80AhT+8c8hyOBTJim5VkffKOmOgoApNCWGIF2Y5JIqt9nG/fGnzd2Jq9IxPExOR0C1DJyNz5RcdAKAKjxRrywaTPBHpUciKiEkhVPoeal8wqCUKBe+eDVG4mKx/KnmBueaAOc1hhJdDaXVl7kdazZ7p2baYQ7gY3E/LV29LNdsLviP1U/pUMwVFCtjyz90e3vQBnSedLgOcEdABx+dRSITw5w/qOlWZ3IAVmyvYL0qpIcDax3c546UANJQv8xBcDgkcVFIxbIZsv654okO4bXGfTaelQSFfusxB7elADZCFySct6mq5Yn2Y9Gp0hIPzEH0NV3ZnP7zr2IHWgBXbOQxAI/WqzsCTng098A85J7E1Cx+bDfnQAjSA8EnPtUMjDPT2p0hAGB371AzE8d/WgBD+VMYDtyaRm6jvUZP4UAKTTSfzpCc0ygByH96n1FFEf+sT6iigD0a18TWzMVmZAM85rotP12znG2Mr9c4zXmU2nx7nZSSMmojZSRglHYHHQGgD2y0u7VjtV0J+taELQP8Ae5PUDNeD293qFmP3czgemav2fifULXJf5/ds0Ae8RNEUwxxircRhZOGArxmx8dsABcBwe+ORW9ZeMrecjLqq+/WgD1G3ER6Dn1q/CqrhpmGOwNeeWPiNJOIpVKjq2a0oNejkcBZd7fpQB3iyA/Nxj0Bq9bPGgDHcuec1w8eqbiplZMDptNX4tSMhBZ9qD1oA7OCYFjhlYnue1ZPjq6+x+FdRndvuxEDB71nw6lHn926sc81y3xZ1NR4NuVRyHcheDxQB4jZ3OycNnGTkn612NpcF0XaxIx0rz6J8OD6V1WkXBeMAHpQB0sczZ6kkVYimIPTrWUr7unT1FWUuFwM0AX5JSx2k9KUBWXJPSqavwOetSoQRx1oAlKgkYpyxAMD1HvToyobBHbPFTO2fukKDQBZtZIwV3LwPyq6s0DdOD9KwpI3fjeePSmhJF6uwX1zQBuSlCAF25NVyFBOX5rOAIGSxz6mm+Zu+UPx0zQBNMQTweagkJwQODTnMaDuSKqyzhuxBNACFwpJzzQlyQen41Tmmxk5AA4z61E1wAPlOT1xQBtx3LnFWomLEfKffiuftrnaeTnvWnbX7IwPDex4oA0XB5DZU+lRtE22nLdxyANIQT71MJ48DoR+VAGLdQvnGM5qk1mHySuWrpLqKORN6Zz7VQ27S2AD9RQBkx6eFKjAya0baDYRkCpoUy2Sq/hxVlIfm+7x9aAESNeOmKtxhAvBIxVXZhtsaAfWlJMf3wR7GgC4Z1UgCPeeoGK0Le6klt9xjIx/yzAxmsGWTywzeYyYGQVGTRZ6uODIRE3TzWzz+FAHRtI6RHcojhb+EZzTN8iIyIhSM/wDLQ8mqSXcqtvjG0nne7HB+lNNy0jlg5lBPIY4AoAv7/m2Bg5/vsMYphUlyUO9xwfn4rNmvEAHmHcueFQGlbUOQpXZ6YOSaALcyMTudeR2U5zWfdBgGYnamOg4qVbovnZCVk9WOOKgu5ikLugaRjwcnIFAHLyRkyFtrGP3PIqKYhELRphD3PLGrexATJHIXJ6g9qhZ1bLxxye+R1NAGW4BjyZP3f9wDP51C7LGu0Dch/hFaU6yOMRrs/wBgDBP41nND5ZbZuJ7oOaAKVxKxGBgL6KOlVnJ7neD+lXGLsCFTAHUAVAw2jIJY9welAEGDwXwF9TUbSBMjGc98U9g7E4IK+hpuFQZRc+pPWgCCXdj5h8pqvIVQcDI9asSuuO5HuazZ5PmIHI9KAGyPk4PTtUJPODQTmm4oAQ59aYaeRzSY9qAGH8aa3NSMMVG5AoAdF/rE+ooqKOX96mAOoooA7eV03ncNq5OFWmGSMjLDYPU9agJYMzYCDJO5uTSpE0gDKGdum5uBQA8GMsxVN2e7VE8CyZ6Mf0FWYbSdiNilz068CphaTL8hwSeyDigDIezj5GMt6LVZ7N06Egnt3rpE0+f+4F9gOaswaNNIc5CL3ZhzQByQkuoV4dwPrWnYeJbu0UIMbe/FdJF4c8w/e3e5HFEnheE9fmbpgUAUbfxjt5ZSW9z0rZs/GcDsnmSN05HvWTceEBjcfl9MVnSeErj/AJZk49TQB6PZ+JLd4wXuo1XH3QRms3x9qUF/4dZYSM7hjnk1wB8N36k+WCxHpxTJdN1SEYIlI9OtAGepOcEYrW0q42uMtgVn3VrcwKr3EboM4yRTLeXawPegDt0uCY1ANSpcADLNgVhWl2dowc1fSXf2zQBqxTA8k8VcjmVe+TWIjGM7kyD6GrMMoY5bg0AbMcxJ+QA+pNSKyk/M5J74rK84AYB60qyndgnigDYSQA8Hih5kAy/UnpWVJdKBwSKhN0GGcHP1oA0prtc4xnHWq7agyrxGqj1qiXDD5sAVXmuF4AxgevSgDQfUSep/IVTlviTgVmzXTHowwKiNwueoagC9JcM3VsCmCXceCc4xVBpyTnGAPTvTZZPkLGRlB6CgDUglHTOfXmrSXOwjH61zcTMMNuJ9M1ajuSDliSKAOqjkEqYD89SM8VLG7DPznA/KsGBt4yj49quxM/Tfn8M0AbltdAfKZOvtipyQ4wGBx6VixzuOO4q9DKCMBjknPNAFloyqgjr6U+OQqwJJxUYYspHIPrTG+6VkYj6CgC956AnP51DPcBmJ39emTVTaMARkkH/Z5pCoQ5Y/mKAJvLnuUl2RySgLz5Zwar2OnXFtg7mAbkgcj8T2rpfCdh9sgupo42YLhS27AFaz6WXASQSZxwqj5D9TQByWyV3CswXHZ2z+VI0E7nDfPjoxfAH1FdFNp8SoVZYlA4KqMsD9ahk04KAUGGxndIeDQBibZFfZuKuR0RflNKln8vyFRgfNk5Oa1fsZO7ky84aNT0+lSGBl2/LDHjoxGGP1oAyktHbBIaT0JOKi1OVoYAqyKJT/AAZHP1rbZQVPzk5PIXsawtcQ5PmlV2jCtgbj+NAGBA3nzu0m5H6BR0NaMau/DECQD7+OKhtocp+/GSTw3r7VorCEAV/nA+6CelAFLyixw26Mf3sctUM0C7doba/bHetF+uW2s3bg4FQTBMYdtzddwXpQBhz2SScZ/e/3s8VTfT5WYk8be/Y1tzvEqnzMiPs2cVharrEKptB4HTDZoAglgRcmV9hX1GM1kXt9ChxEmW9T3qrfX8tzjcx2gcYqiWyeef50AEkjSMTjGajIANPxx7U0gDvQAxiO1J+lO46ZprEKfWgANMZgO9RSSHsKiDEt6UAPeUZ4NMcggYPNI3zHNMoAdFgSpj1FFEX+tT/eFFAHQfvDK5aZRyevNTC9WMjdI0h9OgrNkY+a5JPU00DJzmgDZ/t1kULHGFHt3qeLxK8SERxbSerdaw1GTgVIqAnGAT7nAoA6GHxb5aj9xvcD7xOKlHi853PCWPYZ4rmgiHPA/KneQnXr9KAOik8ZXL4VYljT0FRDxfeBtyooP1rCFsD0NH2Yc4yfYUAdJD4xuVbLwo7Vai8WhmzcQtnPRelcmtuT0BNHkkZwSaAO4tvFlsf9ajKPQLmrMXirTmlKpEEz1dhXnwQ4FKiYPQUAdl4iv9N1LTmhSYmYncpxjbXKxWEaAF7oFj2Rc1CqZ6n6+lSqOODxQBoWsCkgRyk/7wxV8LNb4MsZ2noQODWTACjBlOee/T8q6SxuGIHmSYTuOufwoArLOWGVwakWTuR+Va8UelXsgUQyxkDlomx+JNJ/Y6Sbja3KtGvduefQetAGaJPl7ml82Qr8p5q42j36A7YlkGOiMCfyqnLbXcALSW86KDzlDQAw72b5s4p24KPlPNVmuM8Dr71G2885oAmlmPOO9UppjnAOQKftLetQyAKfegCPLFuc49BT1THYClB46Uo45zmgAApsqbmDH8M1L8uAc0xpFHU9KAAgkAk/jTQ3JRuR2qrPdAthelMjuAPv9KANO38xGxkkeladtKRyeQKpWEqTD7wJrctoVCH5eM0AEMyyDoAferKNgjgACqskIOdowOo56VEsssRIYZA9aAOhtJImUB8/hU0iKTuXOKwIr8YxgKavpMHRSHwO/NAF0gqCS2R3qNgp7gikEmcYOcd6aT13ZH4UAem/DmzjTw9JM+Skspwg9uK27yFPLKyARxk4UKeRSeCrZbfwtYhd5dlLH05NX5cAEMPMz2IzigDmbm12lvKURsONzrnIrKnhC8qGmXdyCeB74rp7m2DsBLIGcfMu04xWTcxHdl35AwU65oAwZVJfG/y2H3do60xgXTBQkd9xzitCZCqY2hYz0PcVUaLdySzEdQO9AFZyyDlwGHOAOorndSjbHmPtMLnvya6ebOwmMKuBxv61zVzbrNcgh2ZgfmHY/SgBlsRj/RVDD1PRBUobarEEkfxPU7bUUgfIwHCqOtZ11LgnZnd3XoKAG3MqxRMw/wBX9eTWLfamkSHJ3J/dJ5qLVLrycsHOT/COgrmLySW5cldyoaAGarqkk7FFYeWDwBWUzZJznNXGt8Lk8k1E0PB3YUe9AFbIpvzH7q9asZgjPzEmq0lySSEGBQAOuOXeomZB0OT71GxyeTTT1oAc0h6YpjNmg0xj7ZoAaRgAVFznipTlh0pqo2c4JoAb83vSovzcin7W5+UgUD5cE5+lAD4kHmpx3FFEbESIdpxkUUAXJD+8b6mhSAKgaYeY271NPVhkc0ATjHGKlXI6darq3tUqFNtAD1fBxipN244qJeOQM1MmR1SgB4LHA7CpVf1pg38ALgd6kWFmbtj16UAOWRRnPJ/Knx7iM7R9PSpYo8DGxD7j/GnhWU42ov8Au/40ANSFn5YBfc/4Uv2Uc8ge5p+7njJPr1/WpVOGwF59RQBUNqAwBP8Aj+VOMBHIUflzVtcDBIHuBU0ZHPyjB9f880AUBCeOua1dMIyVZA31NM8sHjaP8+1WIo8dG59AKANS12gMQoUd+Mfp3p6PI0rZJUDpxg//AFqjjBBA/hxy2aHkVZTtyc+vSgC5FceVgCR92egOMVch1O5jUfvJAB0DHP6VlCTaANwGTk4HJqQAthnJ/OgDWF6txnz7a2lY/wATxgkUySx0qdcSWKKe7RMVzVNWAAAPNSLKEXvigBzeHtMckxy3ELAcDcGqs/g62mJZNUdT1CtEDzVoSkgEcd807ziOpOfrQBlz+Cpwf3Op2bD/AGgVpv8Awguq8BLixfP92X/61axuMD71Up9VihP+syfagCjN4I8QIh2RWrf7swNV08Ca5LKFmWFAT/z1Bqy/iaaI/uG5znLc1Na+LrpTumgWZTx0x+tAF23+Glu8Q+06gIJu+5hirlr8JknYhNasMdj5nX6im23i2wIHm2c6kjkgZxWrBqWk3SBo7pY26/ONpFAFuz+A01zEssWs2qJ3aM781fuPhHfaW8Sf2zBLC+ADKm0/zqrEsuM29w3lk8eXIcE+vFPmnneJY5ZJSEORuYnBoA3rf4PvKmf7XQP6eV/9eorv4M3zRHyNQtpCPVCDTdG8WXemKsMuLi3HPzE7h9DXpXhvxTYakBHbTq0v/PJztcf40AeI6h8I/ElvJiJLadf7yviqg+HXieAESWKuB/clFfSq3UjMwMBQ+9OSV24KAUAfMMnhDxFACW0yf/gJBqlLpOrxsVl069A90NfWGxWA3KM1BcwxCF2KrhVJPFAHK6RCsWk2cEajekS7txxjjpTpAW3LGAPU+tNNxEykxrtB6mozKGU/MFUDtQBVnjGGVUAPdjWZdQjcBEAHUcMRWvI6sOAAvr3qncDzMF1Kxg9u9AHM3avuZsbv73pWe4zgO5HdSvH4V0lwqvkkELzxjk1jXUZWMssahOp55z64oAy7tMwkkFxnrn7v4VheaFd94GegftWrqMgWLG5y+OVHSuYuLlVBCsHPdW7UAT3dyQhVD1P3u5rEvr0qMuQSPTj86ZcXX3irlQOqngGucv8AVoUZgDlv7oGaALNxvmbdKQw7YqpNNBCPmYDHbvWLPqc8v3TtX0FUmZmOWJJoAv3OoM5+QADtVKSZn+8xNRn60h20ABamluaCRjpSZoAOTRj1pQrk4ANSpbSHnGKAICvrTkjzwBVtLNu+KnW3IGAKAKkVuDgnHWrKwDjgVOkBB5FTiPaAcUAZ5Ta3I496f5akDgVZuIspkCq0ZwcGgCSOFPMT5R1FFSpw689xRQBiSpiZ+O5qPDgcfnWi8WZHOO5pDAM470AUYpHH3utTrKM809rXPamNbt2oAmWQZwGFShiF4aqJhcHpmgNJGe4oA0kZ8Z3ZNSr5jYJaqUN0BxIuPcVoQvDIAQ4P40AHzd3JqREJOSx61OkKkDGMfWpBAzcAjFADFGVGGI9qsRq3YduuaEt5FPOMHoB1qQRSA4CHPcCgB2Aoy2c+lSoAxyecdBTFil6eW1WIoZd/+pbbQBLApYYICj3q7CNxHoPwqqsbsR8hwKvxRIEGQRnrQA5Pmdn27gvc9PwqPcSTgDr3qW4KwwbV4Jqg8h5G7FAFxcA/M1O8xR2J7ZrNM8aYLyBR0yxpg1GEMBEslwewTgfnQBsiV5OFXp6Cp44H2h5WCr15NZ9vJfTEbI0t1PYcn860rXTWuZVRjLdy/wB1TnB/kKAGtcQJgKxdvROaguJpW4jjCt6dSa7bR/BtxIB58WzJ+6g5/E/4V2ek+B7eBBJLEMr/AHuaAPDTpGr3L48qTB55FWYfBWpyrlkY+mOlfRdr4dtfvbBnqBjrWtFpFrbQlniRj1wRQB82QeA9R2k+UAPXFPPgvUBwEyfQCvp2y0u2njciJA68jA+8Kc+g2o2loxzz9DQB8ut4S1Nf+WJOKiXw5qGQDav74FfUa+HrU/MV47qRQ3h2z4KxgsPvYHWgD5pj0LU7cMVimUYz8ppzTarGoUNIR1+Zf619Kf8ACNQNGQ6hV7ccj61nzeC7RlKqBtI4780AfOz6hfY+eNT25WqMms3UUoYRlJUOVZWIIPrXu114HCBwY1cE4yBXK6x4DOxt9vtYdCtAGb4W+N97YFLbXrZ7y2HBlU4kUf1r3Lw7reneI7Fb3RruO5hIyQD86H0Ydq+Wtb8K3NrKymFhjoMHmqvhq+13wtqa3+ktLAQcMGPySD0IoA+wWBxxWX4huRaaXK7Nt3fKK4TRPi9pd9bL/aKmxuwPnXGUJ9jXO+L/AIk2F9OkMMjeQnO5R1NAHTG/Rk+bKhecdzUUuoIDlmG3sPWvL73x1bBgYFkZhwWI61j3XjuTkx2xz33GgD2F9WjjbLbT6DNVpNVRiN2CTyADXi83ji8IxFAiqfVqz5vGmr4IVkUdjigD3BtQjLFyw3j+EGs+7u1kkJDAqf4Sc14nc+LtZlXm5Cn1Vay5tZ1SVWBvpgG64NAHqniLU4YCwmnSJMfKQa8+1bxNAHItwJZMYD9BXMTGaYkyyO/+8c1CYj2oAsajq11fYE0mFHQLxWeTmpfKJOOKcts7H5VJoArkmm81ox6ZcyfciJq1Bo8zMA8bD2oAxVjZulTJZyP0FdTb6QoXG0k/StGHS8YCoPxoA5CLSXPUEVai0sJ97n8K7SHS8rzwfQCpF0+NTyDQByMdhjoM/hTxZc84rrDbRjgKOuaZJaI3IUcdcUAcubHAycYpfsoxzitqWAYPH0qrLDt6DrQBmmIZ7UyVMDA7VekjGarTLigCvt3KRWbOhSUcYrTXjINVb1P4gcj60ANiGWX1yKKdbcsmPUUUARMoMjfU1IqU1v8AWN9TUidKAHCIEYp624PWpExx61Og4oArfZA2cUh04OOgrQVcdKsogOM0AYZ0oE9P0qNtHPOzIrqFjBPAzU6RAkEjJFAHIrZXkIzG7H605bnUYOWjDj6V2ot1bHoetSrax/3QQOKAOI/ty8TjyUU+u2geIrnj5E49utdu2nQSjBhVvwqhdeHrV+sYX6UAc7F4muR/yyjqzD4nmyC8MZHpmrw8Hi5YiE7B6tW7o/gKyiCtcl537gnCj8KAMSHxPAQPPgCfQ8VpR63ZS7TG69O/NdbaeFdOUD/Q48Z4yM5rdtNEs4R+7tok+iCgDyXVdVaSTbBDIy+qoTVO2h1K/bZbWly7Hg4Q8V75DZwjGEXHpjmtOGEbQBGoA9BigDxDSPh9q97KrT23lgnkyt0/Cu40z4alConu0Uesaf416PFFx8y89qvQRLG2QV9ST2oA5TTPh5pkRDTiS5JPHmOcfkK7Cw0OxtI1SG2ijI42AAcVZiGBkHAxw1WkYhRkc+vrQBYggiTCqg2n+EdqkbGMZGBzUcLkrz93HNNvHUQsw4G3gCgC9a7VXO0Bcc/WqeosfOii3YDsAF68VJZuBEmfbI9qrQyZ1ZpGwVj6E+ntQBvWxWGNExhl44qV3LAoowTyc01pAqk5Bcim7/mCkk8cUASouQNzbvWpwoUjGA3rVdXKjKjjv70ryH1yO2KAJWCgZz161HuUE4JxjjFMXLHLHj1pdwC+n9aAEYl84GAO9RG3wPnGQeue9Ss+MqMEf3aikdyByCB+lAGfdaZa3WVlhVwBkEjnNcp4j8G2twrGJAHweMcV2qsRNIeRkAmhiPLxzjv7UAfNviXwo9vJIY0xjqD0/CuGuojExDjBFfVPiHSYr2MlQC/b3rxzxR4UZ5XKptOcfjQB5VIcdMVVf2rprnwveo5UISeoFVz4aveMrjNAHNsvrSFQVrp08J3jH5h9RV2HwdKcZyT6UAcI8fUYqNouTgcV6bB4LU8Opz3NXo/BkAGGiPbBoA8f8hz0BNWINMuJvuoa9ij8IWynPkEeoq3B4dVOETC49OaAPLLDwxJIcuMDHet2z8ORx4BA/EV6Imi+WRvA/wA+tS/YFTOFGaAOPs9IC/djA+taEekRjBaNWP05rcdFA4AI/lTGbsevrQBkPptup/1ac1BLYwgfc2n1X0rTlPIIzk1WkcDgfjQBRe3QYK5BHY1Vnj64q9Mwb6VWkPyEjFAGXJEwGcD8KqszBjnjFaU5+XmqcuDx1oApyOrDB4qpLz3/AAq3Ooz6EVRlXjjrQBVl6+lVpMY5qeQHuarMTkigCs+Ac96juMGPNSuByagboaAIrIjzADj7woqG2O26A/2qKAHk/O31NTJmoDjzG57mp4uKALEIJ5xVpFJ+lRRYwKtIKAHRqatwoe9RRirUR7dqAJEXaM5qzH90E1HGARnFWo0B+lACoOeO9WI8ZApI4wRgCrcMGRxQBPAgwMjFWDbwsCxG49gKjjicYA4UVftoWcjAyKAFs7bkA9K1LeDA7UQwEkADFX4bfgH2oAIISe4xV2ND+ZxS20Iyu4f/AFq0I1UE4wTQA2BO44H61ciUqAT930pIVXAPfPPvVhSNwx0oAVQS3XkdKsIFUg8kn+E0xAucjcM1Mq85zjFAFiNgCNxyD0FW0kGCDyf5VSUAIWBIz1qZFYoOMDjHvQBehOXAU/N06Uy+cfZJTjpxSRqyHDAhhUGtP5emvt4J45oAfbT7SAW3bRyPeptLiLXW5zk7t2OwrM0lGnVWX7rnBJret4RCqov32+8fagC9GdzM+ec/hTu/HTOQajTHl/JzjtTgcA89RwPSgCwHYcN8o70oG0HjkDp61D5pzgHkc1ISWHL4yOtADt/GOvt6U3B+U549acMKFOOnb1ppfP8Ah6UAIAeecHsT3qObiMgnb7VKW79R/Kq8yhkIJ5xwaAAsdgOcEHGfWorhyDk8kD86fbnbEpHIwcg1WlYAsrHOfun0oAjmwUB6Kc4PoaxNSs0uDuYAY4etSeTCZIHQg+1VZ2CuGI74x68UAcxJoe7IwNw5B9RTR4eB+YIPL3YJPaurtwrnaccgFT+PSrZAVSQpx0IxQByA8OqGVTjd13etObQ40ckjkV0koXbjtjNVHyUGQAD0oAxl06JBgLxnJNSPZxnkAEDtjpV5/mHIwRxUMjYPHUDn3oAovCmR8oyehqu8Q+6AA4FXWIzgcqe9VpRwFzwP4qAKEkZBYjkHrmqjgKMEnbnrV+UgkgfeH61WkAILL9CKAM6dQWx90/zqm6MCeADV+b7hHX3qpJnn1PegClIBznIHeqUi9x+FaDjPTr3qlOApx2oApSJubjg1TlQDO3kd60XIPGPpVJvvEUAUXG7jJ49apyKd57Voypk8HjuKqyqMACgDNmU5qrIOo/WtGVfl6VVljAPA4I6UAZsq547iqsi+taMqAfSqkqmgDOlTg4qu3HXpV9xweKqSrQBndLqMj1FFSTDEqHvuFFADN371vqanRuBT1jQSSYRevpViNEz91fyoAWEgDk1aRqbEi5+6v5VbVF/ur+VABE2atRnkU1EXj5V6elXIUXI+UflQA6A4Ye9W0YjvzTURdp+UdfSriIu0fKPyoAdCRxyOetX4mXIBPyjsO9VI1XB+UflVpFXK8D8qALkcgZuDux29K1LaYHB49OO1ZMKjzRwOladuo2HgflQBowNg561dhkAIB/SqUCjb0FWlA4470AXo5tq8Dr271ajkXAyapIBu6CrKgegoAtxy7gf7oqUSYz6GoIgM9B0qUAZHHagC1FJwCc8dKshznJ6noKrRgfLwKsKB83AoAlVy23g1YjcqrAncc8Gqyd/pU4A29KALgmzhAcN/eNZfiicpp6qDuLMB9T2rQgA8npWL4p+/bDtuFAG1pJZIFJwE2849a0En3sOQM/KuayrH/jxX8KvQgedHxQBfMw3nA+XoPapUZSM9B3J71StOWfPPzU9/vUAXUlGPmGR0xT/PwR8ucdBVKOpk6fj/AEoAsCU52lsnrmk8zOT0x1NRRAFRkZqSUASsBQAGTgg8j0FV53YqA2QM8EdqkPWs27Y+U3J6HvQBOZ9iEp1XIqn9oG9xn5W7+hqt/wAsk+tMuAMPx/FQA6WcDIx8wGDVb7QVORktk4HrRN1/AVWAGD9aANG0YeYADgHp7VpMx6E1lWgGxuPSr833VoAikba3B5PaqsrEE4ORVmQDYDjmqjAYPFAEBc/d9e/pVaVvzH61aIGDwKozdf8AgVAEW7ksDz3BqvO+FJz8vp1qZwPN6fw1XlA9BQBBIQUBb8CKrO+cFfvAY5qyAPLPA61WuAPMTgUAVJny2R+IqrO2MHsauSqN78DpVYqNh4HbtQBTlI9cGqUhzk8c1oSqNvQVSkVfQflQBnyMBkA1WkOCemfWr8qrk/KOvpVWVV4+UflQBQkYlSR17iqpOfXFaM6r8nyjp6VVCruPyj8qAKEjcYPHvVZ34x0NX5lXn5R+VVpkXYPlH5UAZzkYOOpqlK3Udu1asyLx8o/Kqjou4/Kv5UAZj8E1VmPJArTdF5+UflUDonlk7V/KgDHkAZ1HvRV5o0JTKL1HaigD/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Cory K, Valin N, Gozlan J, et al. Bipolar Hypertrophic Herpes: An Unusual Presentation of Acyclovir-Resistant Herpes Simplex Type 2 in a HIV-Infected Patient. Sex Transm Dis 2010; 37:126. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15058=[""].join("\n");
var outline_f14_45_15058=null;
var title_f14_45_15059="Scapular strength L PI";
var content_f14_45_15059=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F53445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F53445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scapular strengthening exercise - \"L\"",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 346px; height: 440px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Position the arms to form an \"L.\" Hold arms bent with upper arms and forearms parallel to the floor.",
"    <br/>",
"    (B) Rotate the arms so that the hands are pointed toward the floor. Hold for a second or two, then return to the starting position; repeat 10 to 15 times.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15059=[""].join("\n");
var outline_f14_45_15059=null;
var title_f14_45_15060="Halcinonide: Drug information";
var content_f14_45_15060=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Halcinonide: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?31/52/32579?source=see_link\">",
"    see \"Halcinonide: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F178345\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Halog&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F178371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Corticosteroid, Topical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F178348\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Steroid-responsive dermatoses: Topical: Apply sparingly 2-3 times daily, occlusive dressing may be used for severe or resistant dermatoses; a thin film is effective; avoid excessive application. Therapy should be discontinued when control is achieved; if no improvement is seen, reassessment of diagnosis may be necessary.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F178361\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F178349\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F178333\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Halog&reg;: 0.1% (1.5 g, 30 g, 60 g, 216 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Halog&reg;: 0.1% (1.5 g, 30 g, 60 g)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F178319\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F16061121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For external use only; not for oral, ophthalmic, or intravaginal use. Wash hands before and after use. Apply a thin film to clean, dry skin and rub in gently. Avoid use of topical preparations on weeping or exudative lesions; occlusive dressings may be used on severe or resistant dermatoses.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F178334\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of inflammatory and pruritic effects of corticosteroid-responsive dermatoses [high potency topical corticosteroid]",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F178375\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Halcinonide may be confused with Halcion&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Halog&reg; may be confused with Haldol&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F178369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Frequency not defined. Adverse reactions reported with topical corticosteroids; may occur more frequently with occlusive dressing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Intracranial hypertension (children)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Acneiform eruptions, allergic contact dermatitis, dry skin, folliculitis, hypertrichosis, hypopigmentation, itching, miliaria, perioral dermatitis, skin atrophy, skin maceration, striae",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Cushing's syndrome, growth retardation (children), HPA axis suppression, hyperglycemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Local: Burning, irritation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Renal: Glucosuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Miscellaneous: Secondary infection",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F178338\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to halcinonide or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F178323\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal suppression: May cause hypercorticism or suppression of hypothalamic-pituitary-adrenal (HPA) axis, particularly in younger children or in patients receiving high doses for prolonged periods. HPA axis suppression may lead to adrenal crisis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Contact dermatitis: Allergic contact dermatitis can occur, it is usually diagnosed by failure to heal rather than clinical exacerbation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Immunosuppression: Prolonged use may result in fungal or bacterial superinfection; discontinue if dermatological infection persists despite appropriate antifungal or antimicrobial therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Kaposi's sarcoma: Prolonged treatment with corticosteroids has been associated with the development of Kaposi's sarcoma (case reports); if noted, discontinuation of therapy should be considered.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sensitization: Topical use has been associated with local sensitization (redness, irritation); discontinue if sensitization is noted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Systemic effects: Topical corticosteroids may be absorbed percutaneously. Absorption of topical corticosteroids may cause manifestations of Cushing's syndrome, hyperglycemia, or glycosuria. Absorption is increased by the use of occlusive dressings, application to denuded skin, or application to large surface areas.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Because of the risk of adverse effects associated with systemic absorption, topical corticosteroids should be used cautiously in the elderly in the smallest possible effective dose for the shortest duration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Children may absorb proportionally larger amounts after topical application and may be more prone to systemic effects. HPA axis suppression, intracranial hypertension, and Cushing's syndrome have been reported in children receiving topical corticosteroids. Prolonged use may affect growth velocity; growth should be routinely monitored in pediatric patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For external use only; not for oral, ophthalmic, or intravaginal use. Avoid use of topical preparations with occlusive dressings or on weeping or exudative lesions.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299434\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F178328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aldesleukin: Corticosteroids may diminish the antineoplastic effect of Aldesleukin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticorelin: Corticosteroids may diminish the therapeutic effect of Corticorelin. Specifically, the plasma ACTH response to corticorelin may be blunted by recent or current corticosteroid therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Corticosteroids may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving corticosteroids (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: Corticosteroids may decrease the serum concentration of Telaprevir. Telaprevir may increase the serum concentration of Corticosteroids.  Management: Concurrent use of telaprevir and systemic corticosteroids is not recommended.  When possible, consider alternatives.  If used together, employ extra caution and monitor closely for excessive corticosteroid effects and diminished telaprevir effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F178329\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13293372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects have been observed in animals administered potent topical corticosteroids. Topical products are not recommended for extensive use, in large quantities, or for long periods of time in pregnant women (Reed, 1997).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F13293374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13293373\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Systemic corticosteroids are excreted in human milk. It is not known if sufficient quantities of halcinonide are absorbed following topical administration to produce detectable amounts in breast milk. The manufacturer recommends that caution be exercised when administered to nursing women.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F178339\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Halog External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.1% (60 g): $211.73",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Ointment",
"     </b>",
"     (Halog External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.1% (30 g): $124.51",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F16061123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Evaluate for HPA axis suppression by using the following tests: ACTH stimulation test, urinary free cortisol test; growth (adolescents/children); presence of infection",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F178340\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Ascochrom (GR);",
"     </li>",
"     <li>",
"      Berodan (KP);",
"     </li>",
"     <li>",
"      Betacorton Solution (CZ, EE);",
"     </li>",
"     <li>",
"      Betacortone (CH);",
"     </li>",
"     <li>",
"      Confumin (TW);",
"     </li>",
"     <li>",
"      Cortilate (IN);",
"     </li>",
"     <li>",
"      Halciderm (AU, CH, GB, IE, IT, NL);",
"     </li>",
"     <li>",
"      Halciderm Crema Al (CR, DO, GT, HN, NI, PA, SV);",
"     </li>",
"     <li>",
"      Halciderme (PE);",
"     </li>",
"     <li>",
"      Halog (AT, BR, CL, DE, DK, ES, FR, ID, NO, VE);",
"     </li>",
"     <li>",
"      Volog (AE, BF, BH, BJ, CI, CY, EG, ET, GH, GM, GN, IL, IQ, IR, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, PK, QA, SA, SC, SD, SL, SN, SY, TN, TR, TZ, UG, YE, ZA, ZM, ZW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F178322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F178337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Dependent on strength of preparation, amount applied, integrity of skin at application site, vehicle, and use of occlusive dressing; increased in areas of skin damage, inflammation, or occlusion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Primarily hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Goedert JJ, Vitale F, Lauria C, et al, \"Risk Factors for Classical Kaposi's Sarcoma,\"",
"      <i>",
"       J Natl Cancer Inst",
"      </i>",
"      , 2002, 94(22):1712-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/45/15060/abstract-text/12441327/pubmed\" id=\"12441327\" target=\"_blank\">",
"        12441327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reed BR, \"Dermatologic Drugs, Pregnancy, and Lactation. A Conservative Guide,\"",
"      <i>",
"       Arch Dermatol",
"      </i>",
"      , 1997, 133(7):894-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/45/15060/abstract-text/9236528 /pubmed\" id=\"9236528 \" target=\"_blank\">",
"        9236528",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8512 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-83.177.194.223-8B216F4EAC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15060=[""].join("\n");
var outline_f14_45_15060=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178345\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178371\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178348\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178361\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178349\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178333\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178319\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16061121\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178334\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178375\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178369\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178338\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178323\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299434\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178328\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178329\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13293372\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13293374\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13293373\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178339\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16061123\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178340\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178322\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178337\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8512\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8512|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?31/52/32579?source=related_link\">",
"      Halcinonide: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_45_15061="Tobramycin (systemic therapy and oral inhalation): Patient drug information";
var content_f14_45_15061=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tobramycin (systemic therapy and oral inhalation): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/27/13753?source=see_link\">",
"     see \"Tobramycin (systemic therapy and oral inhalation): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/54/15209?source=see_link\">",
"     see \"Tobramycin (systemic therapy and oral inhalation): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9600303\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      TOBI&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9600304\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      TOBI&reg;;",
"     </li>",
"     <li>",
"      TOBI&reg; Podhaler&reg;;",
"     </li>",
"     <li>",
"      Tobramycin Injection, USP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024676\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shot: May cause kidney function to get worse and hearing loss, and it may change your sense of balance. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3671560",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk to your doctor about using this drug while you are pregnant or if you are planning on getting pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024677\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703044",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tobramycin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024682\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697256",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have hearing loss, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid for breathing in:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697961",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in hearing may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698196",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the kidneys may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698616",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in hearing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024680\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid for breathing in:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696338",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You will use by breathing in from the mouth with a special machine (nebulizer). Your doctor will teach you the right way to use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695976",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle or vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024681\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid for breathing in:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699668",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator or at room temperature. If stored at room temperature, throw away any part not used after 28 days.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699159",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to store the shot closely. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024687\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12324 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-85.214.214.87-1759BFA714-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15061=[""].join("\n");
var outline_f14_45_15061=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600303\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600304\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024676\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024678\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024677\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024682\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024683\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024685\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024680\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024681\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024686\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024687\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?40/20/41283?source=related_link\">",
"      Tobramycin (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?24/31/25076?source=related_link\">",
"      Tobramycin (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/59/35762?source=related_link\">",
"      Tobramycin (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/27/13753?source=related_link\">",
"      Tobramycin (systemic therapy and oral inhalation): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/54/15209?source=related_link\">",
"      Tobramycin (systemic therapy and oral inhalation): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_45_15062="Desmopressin: Pediatric drug information";
var content_f14_45_15062=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Desmopressin: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?9/60/10184?source=see_link\">",
"    see \"Desmopressin: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?31/13/31957?source=see_link\">",
"    see \"Desmopressin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F157823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      DDAVP&reg;;",
"     </li>",
"     <li>",
"      Stimate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F157824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Desmopressin&reg;;",
"     </li>",
"     <li>",
"      DDAVP&reg;;",
"     </li>",
"     <li>",
"      DDAVP&reg; Melt;",
"     </li>",
"     <li>",
"      Minirin&reg;;",
"     </li>",
"     <li>",
"      Novo-Desmopressin;",
"     </li>",
"     <li>",
"      Octostim&reg;;",
"     </li>",
"     <li>",
"      PMS-Desmopressin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1057762\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihemophilic Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Hemostatic Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Vasopressin Analog, Synthetic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1057755\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?9/60/10184?source=see_link\">",
"      see \"Desmopressin: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Diabetes insipidus:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &le;12 years: Initial: 0.05 mg twice daily; titrate to desired response (range: 0.1-0.8 mg daily)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &gt;12 years and Adults: 0.05 mg twice daily; titrate to desired response (range: 0.1-1.2 mg divided 2-3 times/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Intranasal:",
"     <b>",
"      Note:",
"     </b>",
"     Use nasal solution in patients whose dosage needs are &lt;10 mcg or are not met with 10 mcg per spray increments in spray formulation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 3 months to &le;12 years: Initial: 5 mcg/day (0.05 mL/day nasal solution) divided 1-2 times/day; range: 5-30 mcg/day (0.05-0.3 mL/day nasal solution); adjust morning and evening doses separately for an adequate diurnal rhythm of water turnover",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &gt;12 years and Adults: Initial: 5-40 mcg (0.05-0.4 mL nasal solution) divided 1-3 times/day; most patients require 0.2 mL daily in 2 divided doses; adjust morning and evening doses separately for an adequate diurnal rhythm of water turnover",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V., SubQ: Children &lt;12 years: No definitive dosing available. Adult dosing should not be used in this age group; adverse events such as hyponatremia-induced seizures may occur. Dose should be reduced. Some have suggested an initial dosage range of 0.1-1 mcg in 1 or 2 divided doses (Cheetham, 2002). Initiate at low dose and increase as necessary. Closely monitor serum sodium levels and urine output; fluid restriction is recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V., SubQ: Children &ge;12 years and Adults: 2-4 mcg/day in 2 divided doses or",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      10",
"     </sub>",
"     of the maintenance intranasal dose; adjust morning and evening doses separately for an adequate diurnal rhythm of water turnover",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hemophilia:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Children &ge;3 months and Adults: 0.3 mcg/kg beginning 30 minutes before procedure; may repeat dose if needed.",
"     <b>",
"      Note:",
"     </b>",
"     Adverse events such as hyponatremia-induced seizures have been reported especially in young children using this dosing regimen (Das, 2005; Moln&aacute;r, 2005; Smith, 1989; Thumfart, 2005; Weinstein, 1989). Fluid restriction and careful monitoring of serum sodium levels and urine output are necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Intranasal: Children &gt;12 years and Adults: Using high concentration Stimate&reg; nasal spray:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &le;50 kg: 150 mcg (1 spray)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;50 kg: 300 mcg (1 spray each nostril)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Repeat use is determined by the patient's clinical condition and laboratory work; if using preoperatively, administer 2 hours before surgery",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Nocturnal enuresis",
"     </b>",
"     (short-term treatment, 4-8 weeks); intranasal formulations are not recommended for nocturnal enuresis treatment:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oral: Children &ge;6 years: Initial dose: 0.2 mg once before bedtime; titrate as needed to a maximum of 0.6 mg; fluid intake should be limited to a minimum from 1 hour before desmopressin administration until the next morning, or at least 8 hours after administration",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F157804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as acetate: 4 mcg/mL (1 mL, 10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     DDAVP&reg;: 4 mcg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     DDAVP&reg;: 4 mcg/mL (10 mL) [contains chlorobutanol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, intranasal, as acetate: 0.1 mg/mL (2.5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     DDAVP&reg;: 0.1 mg/mL (2.5 mL) [contains chlorobutanol; with rhinal tube]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, intranasal, as acetate [spray]: 0.1 mg/mL (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     DDAVP&reg;: 0.1 mg/mL (5 mL) [contains benzalkonium chloride; delivers 10 mcg/spray]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Stimate&reg;: 1.5 mg/mL (2.5 mL) [contains benzalkonium chloride; delivers 150 mcg/spray]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as acetate: 0.1 mg, 0.2 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     DDAVP&reg;: 0.1 mg, 0.2 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F157789\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1057765\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Intranasal: Using rhinal tube delivery system, draw solution into flexible, calibrated rhinal tube; insert one end into nostril; blow on the other end to deposit the solution deep into the nasal cavity. The Stimate&reg; spray pump must be primed prior to first use; to prime pump, press down 4 times. Avoid spray use in children &lt;6 years of age due to difficulty in titrating dosage; discard any solution remaining after 25 or 50 doses (2.5 or 5 mL vials, respectively) because the amount delivered may be substantially less than prescribed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: I.V.: Dilute to a maximum concentration of 0.5 mcg/mL in NS (recommended: Children &lt;10 kg: 10 mL diluent; Children &gt;10 kg and Adults: 50 mL diluent); infuse over 15-30 minutes; if desmopressin I.V. is given preoperatively, administer 30 minutes prior to surgery",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F157875\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1057758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refrigerate injection, nasal solution and Stimate&reg; nasal spray; nasal solution and Stimate&reg; nasal spray are stable for 3 weeks when stored at room temperature if unopened; injection is stable for 2 weeks at room temperature; DDAVP&reg; nasal spray is stable at room temperature",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1057764\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of diabetes insipidus (tablets: FDA approved in ages &ge;4 years and adults; injection: FDA approved in ages &gt;12 years and adults); control of bleeding in hemophilia A (with factor VIII levels &gt;5%), mild to moderate type I von Willebrand disease (injection: FDA approved in ages &gt;3 months and adults; nasal spray: FDA approved in ages &gt;12 months and adults), and thrombocytopenia; primary nocturnal enuresis (tablets only: FDA approved in ages &ge;6 years)",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F157874\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Cardiovascular: Blood pressure increased/decreased (I.V.), facial flushing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Chills (intranasal), dizziness (intranasal), headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyponatremia, water intoxication",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps, abdominal pain (intranasal), gastrointestinal disorder (intranasal), nausea (intranasal), sore throat",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Transient increases in liver transaminases (associated primarily with tablets)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection: Burning pain, erythema, and swelling at the injection site",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; Skeletal: Weakness (intranasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Conjunctivitis (intranasal), eye edema (intranasal), lacrimation disorder (intranasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Cough, epistaxis (intranasal), nasal congestion, nostril pain (intranasal), rhinitis (intranasal), upper respiratory infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Acute cerebrovascular thrombosis (I.V.), acute MI (I.V.), agitation, allergic reactions (rare), anaphylaxis (rare), balanitis, chest pain, coma, diarrhea, dyspepsia, edema, insomnia, itching eyes, light-sensitive eyes, pain, palpitation, seizure, somnolence, tachycardia, thinking abnormal, vomiting, vulval pain, warmth",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1057769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to desmopressin or any component; avoid using in patients with severe type I, type IIB, or platelet-type (pseudo) von Willebrand disease, hemophilia A with factor VIII levels &le;5% or hemophilia B; moderate-to-severe renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;50 mL/minute); patients with hyponatremia or history of hyponatremia",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1057754\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with predisposition to thrombus formation, conditions associated with fluid and electrolyte imbalance (eg, cystic fibrosis, CHF, renal disorders), in patients with habitual or psychogenic polydipsia or using medications known to either increase thirst or cause syndrome of inappropriate antidiuretic hormone secretion (SIADH) (eg, carbamazepine, SSRIs), and in patients with coronary artery disease and/or hypertensive cardiovascular disease; fluid intake may need to be reduced to decrease potential for development of water intoxication",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1057753\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Desmopressin in combination with excessive fluid consumption can result in hyponatremia, an imbalance between intracellular and extracellular sodium. This imbalance can lead to seizures, brain swelling, coma, and death. The FDA has reviewed 61 postmarketing cases of hyponatremia-related seizures associated with the use of desmopressin acetate. Intranasal desmopressin was used in the majority of cases. Many of the patients were children being treated for primary nocturnal enuresis (PNE). An association with at least one concomitant drug or disease that also may cause hyponatremia and/or seizures was noted. As a result,",
"     <b>",
"      intranasal",
"     </b>",
"     desmopressin is no longer indicated for the treatment of PNE. In addition,",
"     <b>",
"      intranasal",
"     </b>",
"     desmopressin should not be used in patients with hyponatremia or a history of hyponatremia. Desmopressin acetate",
"     <b>",
"      tablets",
"     </b>",
"     may be used for the treatment of PNE; however, treatment should be interrupted if the patient experiences an acute illness (eg, fever, recurrent vomiting, diarrhea), vigorous exercise, or any condition associated with an increase in water consumption. Patients and caregivers should also be instructed to restrict fluid intake 1 hour prior to dose until the next morning, or for at least 8 hours after administration.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Avoid intranasal use in patients with nasal mucosa changes (scarring, edema, discharge, obstruction, or severe atopic rhinitis)",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F157798\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Analgesics (Opioid): May enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ChlorproMAZINE: May enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Demeclocycline: May diminish the therapeutic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     LamoTRIgine: May enhance the adverse/toxic effect of Desmopressin. LamoTRIgine may enhance the therapeutic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: May diminish the therapeutic effect of Desmopressin. Desmopressin may increase the serum concentration of Lithium.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: May enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F157800\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5559903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. There are no adequate and well-controlled studies in pregnant women. Anecdotal reports suggest congenital anomalies and low birth weight. However, causal relationship has not been established. Desmopressin has been used safely during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1057761\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     For all indications, fluid intake, urine volume, and signs and symptoms of hyponatremia should be closely monitored especially in high risk patient subgroups (eg, young children, elderly, patients with heart failure).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V. infusion: Blood pressure and pulse should be monitored",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Diabetes insipidus: Urine specific gravity, plasma and urine osmolality, serum electrolytes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hemophilia: Factor VIII antigen levels, APTT, Factor VIII activity level",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1057752\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enhances reabsorption of water in the kidneys by increasing cellular permeability of the collecting ducts; possibly causes smooth muscle constriction with resultant vasoconstriction; dose-dependent increase in plasma factor VIII and plasminogen activator",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1057767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral administration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Onset of ADH action: 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maximum effect: 2-7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duration: 6-8 hours;",
"     <b>",
"      Note:",
"     </b>",
"     0.4 mcg doses have had antidiuretic effects for up to 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Intranasal administration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Onset of ADH action: Within 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maximum effect: Within 1.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duration: 5-21 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V. infusion:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Onset of increased factor VIII activity: Within 15-30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maximum effect: 90 minutes to 3 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1057768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Due to large differences in bioavailability between product formulations and patient variability in response, dosage conversions between product formulations should be done conservatively titrating to clinical improvement.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral tablets: 0.08% to 0.16%;",
"     <b>",
"      Note:",
"     </b>",
"     Bioavailability of tablet is ~5% of nasal spray.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nasal solution: 10% to 20%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nasal spray (1.5 mg/mL concentration): 3.3% to 4.1%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Unknown",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 1.5-2.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Initial: 7.8 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Terminal: 75.5 minutes (range: 0.4-4 hours); severe renal impairment: 9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Intranasal: 3.3-3.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 0.9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Intranasal: 1.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Primarily in urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1057760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?31/13/31957?source=see_link\">",
"      see \"Desmopressin: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid overhydration; blow nose before using nasal solution or spray; notify physician if headache, shortness of breath, heartburn, nausea, abdominal cramps, or vulval pain occur; when treating nocturnal enuresis, restrict fluid intake 1 hour prior to dose until the next morning, or for at least 8 hours after administration",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F9769997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     1 mcg of desmopressin acetate injection is approximately equal to 4 international units of antidiuretic activity; desmopressin acetate injection has an antidiuretic effect about ten times that of an equivalent dose administered intranasally",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Cheetham T and Baylis PH, \"Diabetes Insipidus in Children: Pathophysiology, Diagnosis and Management,\"",
"      <i>",
"       Paediatr Drugs",
"      </i>",
"      , 2002, 4(12):785-96.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/45/15062/abstract-text/12431131/pubmed\" id=\"12431131\" target=\"_blank\">",
"        12431131",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Das P, Carcao M, and Hitzler J, \"DDAVP-Induced Hyponatremia in Young Children,\"",
"      <i>",
"       J Pediatr Hematol Oncol",
"      </i>",
"      , 2005, 27(6):330-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/45/15062/abstract-text/15956888/pubmed\" id=\"15956888\" target=\"_blank\">",
"        15956888",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eller N, Kollenz CJ, Bauer P, et al, \"The Duration of Antidiuretic Response of Two Desmopressin Nasal Sprays,\"",
"      <i>",
"       Int J Clin Pharmacol Ther",
"      </i>",
"      , 1998,  36(9):494-500.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/45/15062/abstract-text/9760011/pubmed\" id=\"9760011\" target=\"_blank\">",
"        9760011",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eller N, Kollenz CJ, and Hitzenberger G, \"A Comparative Study of Pharmacodynamics and Bioavailability of 2 Different Desmopressin Nasal Sprays,\"",
"      <i>",
"       Int J Clin Pharmacol Ther",
"      </i>",
"      , 1998, 36(3):139-45.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/45/15062/abstract-text/9562229/pubmed\" id=\"9562229\" target=\"_blank\">",
"        9562229",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moln&aacute;r Z, Farkas V, Nemes L, et al, \"Hyponatraemic Seizures Resulting From Inadequate Post-Operative Fluid Intake Following a Single Dose of Desmopressin,\"",
"      <i>",
"       Nephrol Dial Transplant",
"      </i>",
"      , 2005, 20(10):2265-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/45/15062/abstract-text/16014348/pubmed\" id=\"16014348\" target=\"_blank\">",
"        16014348",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Robson WL, Leung AK, and Norgaard JP, \"The Comparative Safety of Oral Versus Intranasal Desmopressin for the Treatment of Children With Nocturnal Enuresis,\"",
"      <i>",
"       J Urol",
"      </i>",
"      , 2007, 178(1):24-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/45/15062/abstract-text/17574054/pubmed\" id=\"17574054\" target=\"_blank\">",
"        17574054",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smith TJ, Gill JC, Ambruso DR, et al, \"Hyponatremia and Seizures in Young Children Given DDAVP,\"",
"      <i>",
"       Am J Hematol",
"      </i>",
"      , 1989, 31(3):199-202.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/45/15062/abstract-text/2500851/pubmed\" id=\"2500851\" target=\"_blank\">",
"        2500851",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stenberg A and L&auml;ckgren G, &ldquo;Desmopressin Tablets in the Treatment of Severe Nocturnal Enuresis in Adolescents,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1994, 94(6 Pt 1):841-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/45/15062/abstract-text/7970999/pubmed\" id=\"7970999\" target=\"_blank\">",
"        7970999",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Thumfart J, Roehr CC, Kapelari K, et al, \"Desmopressin Associated Symptomatic Hyponatremic Hypervolemia in Children. Are There Predictive Factors?\"",
"      <i>",
"       J Urol",
"      </i>",
"      , 2005, 174(1):294-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/45/15062/abstract-text/15947670/pubmed\" id=\"15947670\" target=\"_blank\">",
"        15947670",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Weinstein RE, Bona RD, Altman AJ, et al, \"Severe Hyponatremia After Repeated Intravenous Administration of Desmopressin,\"",
"      <i>",
"       Am J Hematol",
"      </i>",
"      , 1989, 32(4):258-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/45/15062/abstract-text/2816922/pubmed\" id=\"2816922\" target=\"_blank\">",
"        2816922",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13212 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.111.122.2-33308A762F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15062=[""].join("\n");
var outline_f14_45_15062=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157823\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157824\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057762\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057755\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157804\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157789\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057765\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157875\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057758\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057764\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157874\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057769\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057754\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057753\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299137\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157798\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157800\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5559903\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057761\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057752\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057767\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057768\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057760\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9769997\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13212\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13212|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?9/60/10184?source=related_link\">",
"      Desmopressin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?31/13/31957?source=related_link\">",
"      Desmopressin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_45_15063="Evaluation for locoregional and distant metastases in cutaneous squamous cell and basal cell carcinoma";
var content_f14_45_15063=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation for locoregional and distant metastases in cutaneous squamous cell and basal cell carcinoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/45/15063/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/45/15063/contributors\">",
"     Allison Vidimos, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/45/15063/contributors\">",
"     Todd Stultz, DDS, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/45/15063/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/45/15063/contributors\">",
"     June K Robinson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/45/15063/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/45/15063/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/45/15063/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H11115527\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the majority of patients with cutaneous squamous cell carcinoma (SCC) or basal cell carcinoma (BCC), disease remains limited to the skin and is successfully managed with local therapy, such as excision, lesion destruction, or irradiation of the primary lesion. However, in 1 to 5 percent of patients with cutaneous SCC and in rare individuals with BCC, locoregional or distant metastases occur, resulting in an increased risk for mortality and the need for alternative approaches to therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H13999098#H13999098\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Metastasis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=see_link&amp;anchor=H20#H20\">",
"     \"Treatment and prognosis of cutaneous squamous cell carcinoma\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation for regional and distant metastases in patients with cutaneous SCC or BCC will be reviewed here. The clinical features and treatment of SCC and BCC are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7351?source=see_link\">",
"     \"Clinical features and diagnosis of cutaneous squamous cell carcinoma (SCC)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=see_link\">",
"     \"Treatment and prognosis of cutaneous squamous cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=see_link\">",
"     \"Epidemiology and clinical features of basal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link\">",
"     \"Treatment and prognosis of basal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24712?source=see_link\">",
"     \"Treatment of basal cell carcinomas at high risk for recurrence\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19785703\">",
"    <span class=\"h1\">",
"     SQUAMOUS CELL CARCINOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The identification of patients at increased risk for metastasis, and concordantly, the most appropriate work up for metastatic disease, are important components of the management of patients with cutaneous SCC [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/1\">",
"     1",
"    </a>",
"    ]. However, data on the approach to the evaluation for metastatic disease are limited, contributing to the absence of definitive recommendations on the indications for investigative tests and the selection of appropriate studies.",
"   </p>",
"   <p>",
"    In general, clinical assessment by physical examination is considered sufficient for the evaluation of most patients with cutaneous SCC; the need for further evaluation with radiologic studies should be considered in patients who exhibit clinical or pathological features associated with an elevated risk for metastasis (high risk SCC) (",
"    <a class=\"graphic graphic_table graphicRef64366 \" href=\"UTD.htm?35/27/36284\">",
"     table 1",
"    </a>",
"    ). The impact of sentinel lymph node biopsy, which has been used to evaluate lymph node status in select patients with high risk SCC, remains uncertain. (See",
"    <a class=\"local\" href=\"#H2824146\">",
"     'Patients without palpable lymph nodes'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H19785516\">",
"     'Evaluation for distant metastases'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H2824518\">",
"     'Sentinel lymph node biopsy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11115543\">",
"    <span class=\"h2\">",
"     Locoregional evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymph nodes are the most common sites for metastasis of cutaneous SCC, and regardless of the presence or absence of high-risk features (",
"    <a class=\"graphic graphic_table graphicRef64366 \" href=\"UTD.htm?35/27/36284\">",
"     table 1",
"    </a>",
"    ), all patients diagnosed with invasive cutaneous SCC should undergo regional lymph node palpation at the time of diagnosis and during post-treatment follow-up. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=see_link&amp;anchor=H24#H24\">",
"     \"Treatment and prognosis of cutaneous squamous cell carcinoma\", section on 'Follow-up'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The selection of sites for palpation is based upon knowledge of the pathways for lymphatic drainage (",
"    <a class=\"graphic graphic_figure graphicRef69528 graphicRef64606 \" href=\"UTD.htm?15/56/16266\">",
"     figure 1A-B",
"    </a>",
"    ). Lymphatic drainage on the head is complex, and lesions in close proximity to one another may drain to different lymph node basins. Common initial sites for metastasis from lesions on the face and scalp include [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nose and cheek lesions: submandibular nodes",
"     </li>",
"     <li>",
"      Lip and anterior mouth lesions: submental nodes",
"     </li>",
"     <li>",
"      Auricular lesions: posterior auricular nodes",
"     </li>",
"     <li>",
"      Posterior scalp lesions: occipital nodes",
"     </li>",
"     <li>",
"      Anterior scalp, forehead, temple lesions: parotid nodes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The cervical lymph nodes are additional potential sites of metastasis and also should be palpated in all patients with head or neck lesions.",
"   </p>",
"   <p>",
"    In addition to palpation for enlarged regional lymph nodes, all patients should receive a complete skin examination that includes palpation of the skin and soft tissue near the tumor. Papules or nodules in the tumor vicinity or between the tumor and a regional lymph node basin may represent in transit metastases (",
"    <a class=\"graphic graphic_picture graphicRef60608 \" href=\"UTD.htm?25/23/25970\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2824139\">",
"    <span class=\"h3\">",
"     Patients with palpable lymph nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;When an enlarged lymph node is detected on palpation, we typically refer the patient for lymph node biopsy via fine-needle aspiration (FNA) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/3\">",
"     3",
"    </a>",
"    ]. Alternatively, the lymph node may be surgically removed for pathologic examination.",
"   </p>",
"   <p>",
"    If the FNA or surgical pathology results are positive for metastatic disease, further evaluation with radiologic imaging is indicated. (See",
"    <a class=\"local\" href=\"#H11115550\">",
"     'Choice of radiologic study'",
"    </a>",
"    below.) Radiologic imaging provides information on the size, number, and location of involved lymph nodes, which are necessary for disease staging (",
"    <a class=\"graphic graphic_table graphicRef78140 \" href=\"UTD.htm?5/0/5134\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11115550\">",
"     'Choice of radiologic study'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    If the cytology of a head or neck nodule that is clinically suggestive of an enlarged lymph node is negative for metastatic disease, re-evaluation of the site via radiologic imaging, repeat FNA, or open surgical biopsy to confirm the benign or malignant nature of the nodule is appropriate [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/4\">",
"     4",
"    </a>",
"    ]. Enlarged lymph nodes on the trunk or extremities that are negative for metastatic disease are typically re-evaluated via open surgical biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2824146\">",
"    <span class=\"h3\">",
"     Patients without palpable lymph nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Definitive guidelines for the investigation for metastatic disease beyond lymph node palpation in patients with cutaneous SCC have not been established. In studies of patients with head and neck cancer, palpation has been shown to have a false negative rate for the detection of lymph node metastases of 15 to 30 percent when compared to radiologic imaging or nodal dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/5-10\">",
"     5-10",
"    </a>",
"    ]. Hence, it is conceivable that a similar scenario may occur in some patients with cutaneous SCC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/43/36537?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of the diagnosis and staging of head and neck cancer\", section on 'Imaging studies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Factors that often lead us to proceed with radiologic examination for nodal disease in patients with cutaneous SCC include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tumors larger than 2 cm",
"     </li>",
"     <li>",
"      Tumors located near major nerves in the head or neck",
"     </li>",
"     <li>",
"      In transit metastases",
"     </li>",
"     <li>",
"      Tumors invading deep structures (muscle, bone, cartilage)",
"     </li>",
"     <li>",
"      Systemic signs or symptoms suggestive of extracutaneous involvement",
"     </li>",
"     <li>",
"      Multiple high risk features (",
"      <a class=\"graphic graphic_table graphicRef64366 \" href=\"UTD.htm?35/27/36284\">",
"       table 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Clinical or histopathologic findings suggestive of perineural invasion of a large nerve trunk (ie, a nerve with an anatomic name), such as neurologic signs or symptoms",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Perineural invasion, which can be detected on histopathologic examination, suspected due to the presence of sensory or motor neurologic symptoms (approximately 30 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/11\">",
"     11",
"    </a>",
"    ]), or seen on radiologic studies in advanced cases [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/12\">",
"     12",
"    </a>",
"    ] portends an increased risk for metastasis (",
"    <a class=\"graphic graphic_table graphicRef64366 \" href=\"UTD.htm?35/27/36284\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/3\">",
"     3",
"    </a>",
"    ]. In a survey of Mohs surgeons, perineural invasion was the most commonly reported reason for considering radiologic imaging in patients with high risk SCC [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/13\">",
"     13",
"    </a>",
"    ]. Adenosquamous, spindle cell, or poorly differentiated SCCs are most likely to exhibit perineural invasion [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/3,14-16\">",
"     3,14-16",
"    </a>",
"    ]; the facial and trigeminal nerves are most frequently affected [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11115550\">",
"    <span class=\"h3\">",
"     Choice of radiologic study",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) is often used for the evaluation of regional lymph node status in patients with cutaneous SCC [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/13\">",
"     13",
"    </a>",
"    ]. Other radiologic studies utilized include magnetic resonance imaging (MRI) and positron emission tomography (PET). Comparative studies on the use of these modalities for the evaluation for locoregional metastases in patients with cutaneous SCC are lacking. Thus, much of the information used to guide study selection is based upon information from studies in head and neck cancer and other malignancies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/43/36537?source=see_link&amp;anchor=H6#H6\">",
"     \"Overview of the diagnosis and staging of head and neck cancer\", section on 'Diagnosis and staging evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Consultation with a radiologist may assist with the selection of the most appropriate study to evaluate specific targeted features. Patient tolerance for specific radiologic modalities and test availability also influence test selection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H222944\">",
"    <span class=\"h4\">",
"     CT and MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT and MRI are the most common initial radiologic tests used in the assessment of patients with cutaneous SCC [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/13\">",
"     13",
"    </a>",
"    ]. Both CT and MRI can detect lymph node metastases.",
"   </p>",
"   <p>",
"    Radiologic imaging with CT or MRI is also useful for evaluating tumor extent for preoperative planning and staging in patients with large or deeply invasive lesions. CT is superior to MRI for the evaluation of skull base invasion, involvement of cartilage, and bone erosion or destruction, while MRI is more useful for detecting perineural invasion, providing soft tissue contrast, defining tissue planes, and identifying bone marrow infiltration in the absence of significant osseous destruction [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CT is less expensive than MRI, and in many clinical settings, CT is more easily attained. The properties of MRI prohibit use in patients with certain implanted devices. The contraindications for MRI are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=see_link&amp;anchor=H19#H19\">",
"     \"Principles of magnetic resonance imaging\", section on 'Precautions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19786131\">",
"    <span class=\"h4\">",
"     PET",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of positron emission tomography (PET) in the setting of malignancy has risen with increasing test availability and decreasing test cost. PET functions through the detection of the accelerated uptake of intravenously administered fluorodeoxyglucose that occurs in tumor cells. A beneficial feature of PET is its ability to detect metastases in sites of fibrosis, necrosis, and dense scarring related to radiotherapy, areas that may be difficult to assess with other studies [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/19\">",
"     19",
"    </a>",
"    ]. However, false positive results are common with PET due to the incidental detection of metabolically active inflammatory, infectious, or other lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/28/28102?source=see_link&amp;anchor=H2#H2\">",
"     \"Thoracic positron emission tomography\", section on 'Technical issues'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another less favorable feature of PET is the poor spatial resolution attained with this study. The integration of PET and CT (PET-CT) has addressed this issue through providing improved anatomic correlation.",
"   </p>",
"   <p>",
"    Study data on the use of PET for the evaluation of lymph nodes specifically in patients with cutaneous SCC are limited to a retrospective study of 12 patients with cutaneous SCC in which PET detected lymph node metastases in three out of nine patients with high risk SCC [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/20\">",
"     20",
"    </a>",
"    ]. In head and neck cancer, the value of PET for the detection of occult metastases is uncertain; PET-CT may be more beneficial. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/43/36537?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of the diagnosis and staging of head and neck cancer\", section on 'PET and integrated PET/CT'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H222951\">",
"    <span class=\"h4\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;The results of studies that suggest that ultrasound-guided fine needle aspiration (FNA) may be useful for the evaluation of lymph nodes in patients with vulvar SCC and head and neck cancer raise the question of whether the procedure may be of value for lymph node surveillance in patients with cutaneous SCC [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. In a series of 44 patients with primary SCC of the vulva, ultrasound-guided FNA was more sensitive (80 versus 58 percent) and specific (100 versus 75 percent) than CT for the diagnosis of lymph node metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/43/36537?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of the diagnosis and staging of head and neck cancer\", section on 'Fine needle aspiration biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ultrasound spares the radiation exposure associated with CT, but the utility of this procedure may be compromised by operator-dependent accuracy, difficulty in following specific lesions over time, and reduced ability to detect metastases to deep lymph nodes. The latter may be less of a concern in cutaneous SCC, which typically metastasizes to superficial lymph nodes; however, additional studies are necessary to determine the role of ultrasound guided-FNA for surveillance in this population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19785516\">",
"    <span class=\"h2\">",
"     Evaluation for distant metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lungs, liver, brain, and bone are the most frequent sites for distant metastases of cutaneous SCC. We typically evaluate for distant metastases in patients with lesions that have a very high risk for metastasis, known locoregional metastases, or signs or symptoms suggestive of distant disease. &nbsp;",
"   </p>",
"   <p>",
"    CT, PET, and PET-CT have been used for whole body imaging for the evaluation for distant metastases. The comparative efficacy of these studies for the detection of distant metastases has not been evaluated in cutaneous SCC. Data on the utility of these studies in head and neck cancer are available separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/43/36537?source=see_link&amp;anchor=H15#H15\">",
"     \"Overview of the diagnosis and staging of head and neck cancer\", section on 'Evaluation for distant metastases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2824518\">",
"    <span class=\"h2\">",
"     Sentinel lymph node biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early metastatic disease involving lymph nodes may be microscopic and nonapparent on clinical examination and radiologic imaging. Sentinel lymph node (SLN) biopsy is a minimally invasive procedure used extensively in melanoma and other malignancies for the detection of micrometastatic disease. In SLN, the lymph node or lymph nodes most likely to harbor metastases are identified through the use of lymphoscintigraphy to detect uptake of radiolabeled colloid and blue dye injected at the site of the tumor. Patients with sentinel lymph nodes positive for metastatic disease are considered for lymph node dissection, while those with negative sentinel lymph nodes are usually spared from this more extensive procedure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/5/15450?source=see_link&amp;anchor=H12#H12\">",
"     \"Imaging studies in melanoma\", section on 'SLN biopsy procedure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A 2006 systematic review that incorporated data from 85 patients with nongenital cutaneous SCC who underwent SLN biopsy found that SLN biopsy was positive in 17 (21 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/23\">",
"     23",
"    </a>",
"    ]. Among a total of 20 patients who also underwent completion lymphadenectomy, SLN biopsy failed to detect lymph node metastasis in one patient. This false negative result was thought to be attributable to a disruption in lymphatic flow due to the patient&rsquo;s prior history of radiation therapy.",
"   </p>",
"   <p>",
"    Although SLN biopsy has been used in the management of select patients with high risk SCC, data are insufficient to determine whether early detection of microscopic metastatic disease has a beneficial effect on patient outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Thus, the procedure cannot yet be routinely recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19784616\">",
"    <span class=\"h1\">",
"     BASAL CELL CARCINOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compared to cutaneous SCC, there is an even greater lack of data on the evaluation for metastatic disease in patients with BCC. This is likely related to the rarity of systemic involvement; the risk of metastasis for BCC is estimated to be between 0.05 to 0.1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24712?source=see_link&amp;anchor=H12329873#H12329873\">",
"     \"Treatment of basal cell carcinomas at high risk for recurrence\", section on 'Metastatic disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Metastatic BCC most frequently involves the regional lymph nodes, lungs, bone, skin, and liver [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/27\">",
"     27",
"    </a>",
"    ]. Large lesions (particularly those over 10 cm",
"    <sup>",
"     2",
"    </sup>",
"    ) and tumors that invade deep structures, such as cartilage, skeletal muscle, or bone are most likely to metastasize [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/25\">",
"     25",
"    </a>",
"    ]. Perineural invasion, aggressive histologic growth patterns, and longstanding lesions are additional risk factors for metastasis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As in cutaneous SCC, CT and MRI may be used for the evaluation for metastases and local tissue invasion. The value of PET and sentinel lymph node (SLN) biopsy in BCC is uncertain. PET detected lymph node metastases in a patient with BCC [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/28\">",
"     28",
"    </a>",
"    ], but was unable to detect primary BCCs in three out of six patients in one series, raising questions about the sensitivity of the test for BCC [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/29\">",
"     29",
"    </a>",
"    ]. Detection of lymph node metastasis via SLN biopsy in a patient with pathologic evidence for lymphatic invasion in a primary excision specimen of a BCC has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15063/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H959028\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The majority of patients with SCC can be evaluated for locoregional metastatic disease through skin examination and regional lymph node palpation. If features associated with an elevated risk for metastasis are present (high risk SCC), further evaluation with radiologic imaging may be indicated. (See",
"      <a class=\"local\" href=\"#H11115543\">",
"       'Locoregional evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Enlarged regional lymph nodes detected on physical examination should be sampled via fine needle aspiration or surgical excision in patients with cutaneous SCC. If disease is identified in lymph nodes, radiologic imaging to determine the size, number, and location of involved lymph nodes should be performed. (See",
"      <a class=\"local\" href=\"#H2824139\">",
"       'Patients with palpable lymph nodes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The indications for further evaluation of lymph node status when lymph nodes appear normal on physical examination are less certain. We typically proceed with radiologic imaging in patients with clinical or histopathologic features that suggest an elevated risk for metastasis. We suggest the use of computed tomography (CT) or magnetic resonance imaging (MRI) for the initial evaluation for nodal disease. (See",
"      <a class=\"local\" href=\"#H2824146\">",
"       'Patients without palpable lymph nodes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The value of sentinel lymph node biopsy in high-risk cutaneous SCC is unknown, as it is unclear whether the procedure improves patient outcomes. Additional studies are necessary to determine the role of sentinel lymph node biopsy in cutaneous SCC. (See",
"      <a class=\"local\" href=\"#H2824518\">",
"       'Sentinel lymph node biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are few data to guide the use of imaging studies for patients with BCC. CT or MRI studies may be used for the evaluation for metastases and deep local tumor invasion. The value of PET and sentinel lymph node biopsy in BCC is uncertain. (See",
"      <a class=\"local\" href=\"#H19784616\">",
"       'Basal cell carcinoma'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/1\">",
"      Brantsch KD, Meisner C, Sch&ouml;nfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008; 9:713.",
"     </a>",
"    </li>",
"    <li>",
"     Nguyen TH, Joon J. Squamous cell carcinoma. In: Cancer of the skin, Rigel DS, Friedman R, Dzubow LM, et al.  (Eds), 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/3\">",
"      Farasat S, Yu SS, Neel VA, et al. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011; 64:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/4\">",
"      Miller SJ, Alam M, Andersen J, et al. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 2010; 8:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/5\">",
"      Friedman M, Mafee MF, Pacella BL Jr, et al. Rationale for elective neck dissection in 1990. Laryngoscope 1990; 100:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/6\">",
"      Ali S, Tiwari RM, Snow GB. False-positive and false-negative neck nodes. Head Neck Surg 1985; 8:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/7\">",
"      Anzai Y, Brunberg JA, Lufkin RB. Imaging of nodal metastases in the head and neck. J Magn Reson Imaging 1997; 7:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/8\">",
"      O'Brien CJ, Soong SJ, Urist MM, Maddox WA. Is modified radical neck dissection only a staging procedure? Cancer 1987; 59:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/9\">",
"      Righi PD, Kopecky KK, Caldemeyer KS, et al. Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck 1997; 19:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/10\">",
"      Merritt RM, Williams MF, James TH, Porubsky ES. Detection of cervical metastasis. A meta-analysis comparing computed tomography with physical examination. Arch Otolaryngol Head Neck Surg 1997; 123:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/11\">",
"      Reule RB, Golda NJ, Wheeland RG. Treatment of cutaneous squamous cell carcinoma with perineural invasion using Mohs micrographic surgery: report of two cases and review of the literature. Dermatol Surg 2009; 35:1559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/12\">",
"      Williams LS, Mancuso AA, Mendenhall WM. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int J Radiat Oncol Biol Phys 2001; 49:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/13\">",
"      Jambusaria-Pahlajani A, Hess SD, Katz KA, et al. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons. Arch Dermatol 2010; 146:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/14\">",
"      Goepfert H, Dichtel WJ, Medina JE, et al. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984; 148:542.",
"     </a>",
"    </li>",
"    <li>",
"     Mohs, FE. Chemosurgery: microscopically controlled surgery for skin cancer, Charles C. Thomas, Springfield, IL 1978. p.262.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/16\">",
"      Cottel WI. Perineural invasion by squamous-cell carcinoma. J Dermatol Surg Oncol 1982; 8:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/17\">",
"      Mendenhall WM, Parsons JT, Mendenhall NP, et al. Carcinoma of the skin of the head and neck with perineural invasion. Head Neck 1989; 11:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/18\">",
"      Ginsberg LE. MR imaging of perineural tumor spread. Magn Reson Imaging Clin N Am 2002; 10:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/19\">",
"      Bailet JW, Abemayor E, Jabour BA, et al. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992; 102:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/20\">",
"      Cho SB, Chung WG, Yun M, et al. Fluorodeoxyglucose positron emission tomography in cutaneous squamous cell carcinoma: retrospective analysis of 12 patients. Dermatol Surg 2005; 31:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/21\">",
"      Land R, Herod J, Moskovic E, et al. Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva. Int J Gynecol Cancer 2006; 16:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/22\">",
"      Knappe M, Louw M, Gregor RT. Ultrasonography-guided fine-needle aspiration for the assessment of cervical metastases. Arch Otolaryngol Head Neck Surg 2000; 126:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/23\">",
"      Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg 2006; 32:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/24\">",
"      Renzi C, Caggiati A, Mannooranparampil TJ, et al. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature. Eur J Surg Oncol 2007; 33:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/25\">",
"      von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 1984; 10:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/26\">",
"      Weinstock MA, Bogaars HA, Ashley M, et al. Nonmelanoma skin cancer mortality. A population-based study. Arch Dermatol 1991; 127:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/27\">",
"      Ting PT, Kasper R, Arlette JP. Metastatic basal cell carcinoma: report of two cases and literature review. J Cutan Med Surg 2005; 9:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/28\">",
"      Ozgediz D, Smith EB, Zheng J, et al. Basal cell carcinoma does metastasize. Dermatol Online J 2008; 14:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/29\">",
"      Fosko SW, Hu W, Cook TF, Lowe VJ. Positron emission tomography for basal cell carcinoma of the head and neck. Arch Dermatol 2003; 139:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15063/abstract/30\">",
"      Harwood M, Wu H, Tanabe K, Bercovitch L. Metastatic basal cell carcinoma diagnosed by sentinel lymph node biopsy. J Am Acad Dermatol 2005; 53:475.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13714 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-82D89F4E57-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15063=[""].join("\n");
var outline_f14_45_15063=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H959028\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11115527\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19785703\">",
"      SQUAMOUS CELL CARCINOMA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11115543\">",
"      Locoregional evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2824139\">",
"      - Patients with palpable lymph nodes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2824146\">",
"      - Patients without palpable lymph nodes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11115550\">",
"      - Choice of radiologic study",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H222944\">",
"      CT and MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19786131\">",
"      PET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H222951\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19785516\">",
"      Evaluation for distant metastases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2824518\">",
"      Sentinel lymph node biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19784616\">",
"      BASAL CELL CARCINOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H959028\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/13714\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13714|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/53/19285\" title=\"figure 1A\">",
"      Lymph nodes head and neck",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/53/24407\" title=\"figure 1B\">",
"      Lymph nodes body",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13714|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/23/25970\" title=\"picture 1\">",
"      Skin metastasis of squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13714|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/27/36284\" title=\"table 1\">",
"      Cutaneous SCC high-risk features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/0/5134\" title=\"table 2\">",
"      TNM stage cutaneous SCC",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7351?source=related_link\">",
"      Clinical features and diagnosis of cutaneous squamous cell carcinoma (SCC)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=related_link\">",
"      Epidemiology and clinical features of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/5/15450?source=related_link\">",
"      Imaging studies in melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/43/36537?source=related_link\">",
"      Overview of the diagnosis and staging of head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=related_link\">",
"      Principles of magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/28/28102?source=related_link\">",
"      Thoracic positron emission tomography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=related_link\">",
"      Treatment and prognosis of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=related_link\">",
"      Treatment and prognosis of cutaneous squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24712?source=related_link\">",
"      Treatment of basal cell carcinomas at high risk for recurrence",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_45_15064="Ascaris lumbricoides life cycle";
var content_f14_45_15064=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F79015&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F79015&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 528px\">",
"   <div class=\"ttl\">",
"    Ascaris lumbricoides life cycle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 508px; height: 478px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Adult worms",
"    <strong>",
"     (1)",
"    </strong>",
"    live in the lumen of the small intestine. A female may produce approximately 200,000 eggs per day, which are passed with the feces",
"    <strong>",
"     (2)",
"    </strong>",
"    . Unfertilized eggs may be ingested but are not infective. Fertile eggs embryonate and become infective after 18 days to several weeks",
"    <strong>",
"     (3)",
"    </strong>",
"    , depending on the environmental conditions (optimum: moist, warm, shaded soil). After infective eggs are swallowed",
"    <strong>",
"     (4)",
"    </strong>",
"    , the larvae hatch",
"    <strong>",
"     (5)",
"    </strong>",
"    , invade the intestinal mucosa, and are carried via the portal, then systemic circulation to the lungs",
"    <strong>",
"     (6)",
"    </strong>",
"    . The larvae mature further in the lungs (10 to 14 days), penetrate the alveolar walls, ascend the bronchial tree to the throat, and are swallowed",
"    <strong>",
"     (7)",
"    </strong>",
"    . Upon reaching the small intestine, they develop into adult worms",
"    <strong>",
"     (1)",
"    </strong>",
"    . Between 2 and 3 months are required from ingestion of the infective eggs to oviposition by the adult female. Adult worms can live 1 to 2 years.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Available at:",
"     <a href=\"file://www.dpd.cdc.gov/dpdx/html/ascariasis.htm\" target=\"_blank\">",
"      file://www.dpd.cdc.gov/dpdx/html/ascariasis.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15064=[""].join("\n");
var outline_f14_45_15064=null;
var title_f14_45_15065="Pregnancy in women with uterine leiomyomas (fibroids)";
var content_f14_45_15065=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pregnancy in women with uterine leiomyomas (fibroids)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/45/15065/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/45/15065/contributors\">",
"     David W Ouyang, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/45/15065/contributors\">",
"     Errol R Norwitz, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/45/15065/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/45/15065/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/45/15065/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/45/15065/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/45/15065/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine fibroids (leiomyomas) are benign smooth muscle tumors of the uterus. The potential effects of these tumors on pregnancy and the potential effects of pregnancy on the tumors are a frequent clinical concern since fibroids are common in women of reproductive age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Most pregnant women with fibroids do not have any complications during pregnancy related to the fibroids. Pain is the most common problem, but there may also be a slightly increased risk of obstetrical complications such as miscarriage, premature labor and delivery, abnormal fetal position, and placental abruption.",
"   </p>",
"   <p>",
"    This topic will review issues specifically relating to pregnant women with uterine fibroids. Fibroids in nonpregnant women are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=see_link\">",
"     \"Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/14/18666?source=see_link\">",
"     \"Overview of treatment of uterine leiomyomas (fibroids)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of uterine fibroids in pregnancy varies between 1.6 and 10.7 percent depending upon the trimester of assessment and the size threshold [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]. In one study, 4 percent of 12,708 pregnant patients had fibroids with a diameter greater than 3 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/3\">",
"     3",
"    </a>",
"    ]. In another, 1.6 percent of 12,600 consecutive pregnant patients had fibroids greater than 1 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/4\">",
"     4",
"    </a>",
"    ]. A third series in over 15,000 women with nonanomalous singleton pregnancies undergoing routine second trimester ultrasonography reported 2.7 percent had fibroids of 1 cm or more [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/2\">",
"     2",
"    </a>",
"    ]. A fourth series of 4271 first trimester or post-miscarriage ultrasound examinations observed 10.7 percent of women had a fibroid of &ge;0.5 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/5\">",
"     5",
"    </a>",
"    ]. This study also noted the prevalence of fibroids increased with age and was greater in African-American women (18 percent) than in white or Hispanic women (10 percent). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=see_link&amp;anchor=H3#H3\">",
"     \"Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)\", section on 'Prevalence'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Increasing parity and prolonged duration of breastfeeding are associated with a small, but statistically significant, reduction in prevalence of fibroids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CHANGE IN SIZE DURING PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most studies that monitored the growth of fibroids during pregnancy using ultrasonography have refuted the commonly held belief that fibroids increase in size throughout gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/4,8-14\">",
"     4,8-14",
"    </a>",
"    ], although there are exceptions [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/15\">",
"     15",
"    </a>",
"    ]. Indeed, the majority of uterine fibroids (49 to 60 percent) have negligible (defined as &lt;10 percent) change in volume across gestation, while 22 to 32 percent increase in size, and 8 to 27 percent decrease in size [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/8,12,13\">",
"     8,12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In those fibroids that do increase in size, most of the growth occurs in the first trimester, with little if any further increase in size during the second and third trimesters [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/8,12,13\">",
"     8,12,13",
"    </a>",
"    ]. Larger fibroids (&gt;5 cm in diameter) are more likely to grow, whereas smaller fibroids are more likely to remain stable in size [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/4\">",
"     4",
"    </a>",
"    ]. The mean increase in fibroid volume during pregnancy is 12 percent, and very few fibroids increase by more than 25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Almost 90 percent of women with fibroids detected in the first trimester will have regression in total fibroid volume when re-evaluated three to six months postpartum, but 10 percent will have an increase in volume [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/16\">",
"     16",
"    </a>",
"    ]. Regression may be less in women who use progestin-only contraception.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"   </p>",
"   <p>",
"    Uterine fibroids have long been implicated as a cause of adverse pregnancy events [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/17\">",
"     17",
"    </a>",
"    ]. However, there are no well-designed studies that provide adequate data on fibroids and pregnancy outcome. Instead, the available information consists largely of observational case series and case reports that are limited by different patient populations; different criteria regarding the size, location, and number of fibroids; small numbers of adverse events; ascertainment bias in selecting study participants; and inadequate adjustment of confounders.",
"   </p>",
"   <p>",
"    Most pregnant women with fibroids do not have any complications during pregnancy related to the fibroids. When complications occur, pain is the most common complication. There also appears to be a slightly increased risk of complications such as miscarriage, premature labor and delivery, abnormal fetal position, and placental abruption, but all studies do not show increased risk of adverse events.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3541764\">",
"    <span class=\"h2\">",
"     Fibroid",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3695835\">",
"    <span class=\"h3\">",
"     Pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain is one of the most common complications of fibroids in pregnancy; the frequency of pain is especially high in fibroids greater than 5 cm in diameter [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/3,18\">",
"     3,18",
"    </a>",
"    ]. The majority of patients with a degenerating fibroid have only localized pain, although mild leukocytosis, fever, and nausea and vomiting can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fibroid pain likely results from decreased perfusion in the setting of rapid growth, leading to ischemia, necrosis (red degeneration) and release of prostaglandins [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/21\">",
"     21",
"    </a>",
"    ]. This hypothesis is supported by the observation that fibroid pain typically presents in the late first or early second trimester, which corresponds to the period of greatest fibroid growth. Another theory is that vessels supplying the fibroid become partially obstructed as the uterus grows and changes its orientation to the fibroid [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3541975\">",
"    <span class=\"h3\">",
"     Other complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other pregnancy complications have been reported in the presence of fibroids, including disseminated intravascular coagulation, spontaneous hemoperitoneum, uterine inversion, uterine incarceration, acute renal failure, and urinary retention [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/23-27\">",
"     23-27",
"    </a>",
"    ]. Pyomyoma (suppurative leiomyoma) is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/28-32\">",
"     28-32",
"    </a>",
"    ]. Clinical findings may include fever, leukocytosis, tachycardia, pelvic pain, and characteristic features on imaging studies (heterogeneous mass which may contain gas). &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3541780\">",
"    <span class=\"h2\">",
"     Pregnancy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Pregnancy loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Submucosal fibroids appear to be associated with adverse effects on implantation, placentation, and ongoing pregnancy. The effects of intramural fibroids are more controversial, while fibroids that are primarily subserosal and pedunculated are unlikely to cause adverse outcomes. The risk of pregnancy loss may be higher when there are multiple fibroids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/60/30662?source=see_link\">",
"     \"Reproductive issues in women with uterine leiomyomas (fibroids)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mechanisms by which fibroids may cause pregnancy loss are not known; the following hypotheses have been proposed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The fibroid may interfere with placentation and development of normal uteroplacental circulation [",
"      <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]. As an example, a large submucosal fibroid projecting into the uterine cavity may compress the decidualized endometrium leading to decidual atrophy or distortion of the vascular architecture and blood flow supplying and draining the decidua at that site.",
"     </li>",
"     <li>",
"      Rapid fibroid growth with or without degeneration may lead to increased uterine contractility or altered production of catalytic enzymes by the placenta [",
"      <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/35,36\">",
"       35,36",
"      </a>",
"      ], both of which may disrupt placentation leading to spontaneous abortion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Antepartum bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous studies have reported that antepartum bleeding is more common in pregnancies with fibroids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/3,10,11,37\">",
"     3,10,11,37",
"    </a>",
"    ], although not all studies were able to confirm this association [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/8,38,39\">",
"     8,38,39",
"    </a>",
"    ]. Once again, the location of the fibroid in relation to the placenta may be an important determinant. This was illustrated in two studies in which 72 percent of patients with retroplacental fibroids reported vaginal bleeding compared to only 9 percent with non-retroplacental fibroids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/11,40\">",
"     11,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Preterm labor and birth",
"    </span>",
"    &nbsp;&mdash;&nbsp;There appears to be a small increase in preterm labor (unadjusted OR 1.9, 95% CI 1.5-2.3 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/38\">",
"     38",
"    </a>",
"    ]) and preterm birth (unadjusted OR 1.5, 95% CI 1.3-1.7 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/38\">",
"     38",
"    </a>",
"    ]) in pregnancies with uterine fibroids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/6,38,41-43\">",
"     6,38,41-43",
"    </a>",
"    ]. Characteristics reported to increase this risk include multiple fibroids, placentation adjacent to or overlying a fibroid [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/8,11\">",
"     8,11",
"    </a>",
"    ], and size greater than 5 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/44\">",
"     44",
"    </a>",
"    ]. As with other complications, this association is not consistent across the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/3,39,45,46\">",
"     3,39,45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Various theories have been proposed to explain the biologic basis of preterm labor in the setting of uterine fibroids. As an example, it is possible that fibroid uteri are less distensible than nonfibroid uteri, so that contractions occur when the uterus distends beyond a certain point [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/18,34\">",
"     18,34",
"    </a>",
"    ]. Others have noted decreased oxytocinase activity in the gravid fibroid uterus, which may result in a localized increase in oxytocin levels thereby predisposing to premature contractions [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/40/32393?source=see_link&amp;anchor=H10#H10\">",
"     \"Pathogenesis of spontaneous preterm birth\", section on 'Pathologic uterine distention'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/0/6153?source=see_link\">",
"     \"Physiology of parturition\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Preterm premature rupture of membranes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to preterm labor, the literature evaluating the association between uterine fibroids and preterm premature rupture of membranes (pPROM) is conflicting [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/2,3,6,10,37,39,45,46\">",
"     2,3,6,10,37,39,45,46",
"    </a>",
"    ]. Pooled cumulative data suggest fibroids do not increase the risk of premature rupture of membranes, and may even slightly decrease the risk [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/38\">",
"     38",
"    </a>",
"    ]. Once again, the location of the fibroid in relation to the placenta may be an important determinant: the greatest risk of pPROM appears to be when the fibroid is in direct contact with the placenta [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Placental abruption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some studies have shown an increased risk of abruption in fibroid pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/3,6,37,41\">",
"     3,6,37,41",
"    </a>",
"    ], while others have not [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/2,8,39,45-47\">",
"     2,8,39,45-47",
"    </a>",
"    ]. Pooled cumulative data suggest the risk of abruption is increased (unadjusted OR 3.2, 95% CI 2.6-4.0) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with other complications, the location of the fibroid appears to be important. Submucosal and retroplacental fibroids and fibroids with volumes &gt;200 mL (corresponding to 7 to 8 cm diameter) had the highest risk of abruption in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/3\">",
"     3",
"    </a>",
"    ]. Similarly, a retrospective analysis of 6706 consecutive pregnant patients reported",
"    <span class=\"nowrap\">",
"     8/14",
"    </span>",
"    patients with retroplacental fibroids developed placental abruption with the deaths of four fetuses, while only two abruptions occurred among the 79 patients whose fibroids were not retroplacental and neither of these resulted in fetal death [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A hypothesis for the increased risk of abruption in the setting of fibroids is likely related to abnormal placental perfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/18\">",
"     18",
"    </a>",
"    ]. When 133Xenon was used to measure regional blood flow in uteri of 11 nonpregnant patients undergoing laparotomy, blood flow was significantly reduced in fibroids and in the myometrium adjacent to fibroids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/48\">",
"     48",
"    </a>",
"    ]. The authors suggested that the endometrium overlying a fibroid may have reduced blood flow leading to placental ischemia and decidual necrosis, making it more susceptible to abruption.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Placenta previa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most studies that account for maternal age and prior uterine surgery failed to show any association between fibroids and placenta previa [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/8,37,45-47\">",
"     8,37,45-47",
"    </a>",
"    ], although two large series reported an increased rate (1.4 versus 0.5 percent in controls [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/6\">",
"     6",
"    </a>",
"    ], 3.8 versus 2.0 percent in controls [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/2\">",
"     2",
"    </a>",
"    ]). The latter series adjusted for prior cesarean delivery and myomectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Preeclampsia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of studies do not support an association between fibroids and preeclampsia [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/37,39,45\">",
"     37,39,45",
"    </a>",
"    ], although one study noted women with multiple fibroids were significantly more likely to develop preeclampsia than those with a single fibroid (45 percent versus 13 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/39\">",
"     39",
"    </a>",
"    ]. The authors suggested that the increased risk was due to disruption of trophoblast invasion by the multiple fibroids leading to inadequate uteroplacental vascular remodeling leading to the development of preeclampsia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Fetal growth restriction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibroids have minimal, if any, affect on fetal growth (unadjusted OR 1.4, 95% CI 1.1-1.7 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/38\">",
"     38",
"    </a>",
"    ]) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/3,8,18,39,45-47\">",
"     3,8,18,39,45-47",
"    </a>",
"    ]. It is possible, however, that large fibroids (greater than 200 mL) may be associated with delivery of small-for-gestational age infants (&lt;10th percentile for gestational age) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Fetal anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spatial restrictions from uterine fibroids can cause fetal deformations, but this is extremely rare. Case reports have described fetal anomalies including limb reduction defects, congenital torticollis, and head deformities in pregnancies with large submucosal fibroids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/49-51\">",
"     49-51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Malpresentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;M&uuml;llerian anomalies are associated with an increased risk of malpresentation, presumably because they distort the shape of the uterine cavity [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. In the same way, large submucosal fibroids that distort the uterine cavity have consistently been associated with fetal malpresentation (unadjusted OR 2.9, 95% CI 2.6-3.2 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/38\">",
"     38",
"    </a>",
"    ]) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/3,18,37,47,54\">",
"     3,18,37,47,54",
"    </a>",
"    ]. One of the largest studies used a population-based cohort of over 72,000 consecutive women with singleton pregnancies in Washington State (1990 to 2007) who underwent routine second trimester fetal anatomic survey at a single university hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/6\">",
"     6",
"    </a>",
"    ]. This study reported a significant increase in breech presentation in women with fibroids (OR 1.5; 95% CI 1.3-1.9). Other studies noted an increased incidence of malpresentation only if the uterus had multiple fibroids, if there was a fibroid located behind the placenta or in the lower uterine segment, or if the fibroid was large (over 10 cm) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/2,8,18,23\">",
"     2,8,18,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Dysfunctional labor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Theoretically, fibroids in the myometrium may decrease the force of uterine contractions or disrupt the coordinated spread of the contractile wave, thereby leading to dysfunctional labor [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/46,55\">",
"     46,55",
"    </a>",
"    ]. Several studies have reported an increase in the incidence of dysfunctional labor in pregnancies complicated by fibroids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/37,46,54\">",
"     37,46,54",
"    </a>",
"    ], not all investigators have been able to confirm this association [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/2,39\">",
"     2,39",
"    </a>",
"    ]. Higher rates of tachysystole (defined as &gt;5 contractions in 10 minutes) have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Cesarean delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies have consistently reported that uterine fibroids are associated with an increased risk of cesarean delivery (unadjusted OR 3.7, 95% CI 3.5-3.9 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/38\">",
"     38",
"    </a>",
"    ]), especially when the fibroids are located in the lower uterine segment [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/2,8,18,19,37,46,47,54,57\">",
"     2,8,18,19,37,46,47,54,57",
"    </a>",
"    ]. The proposed increase in cesarean delivery rate is likely due to such factors as an increased risk of malpresentation (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Malpresentation'",
"    </a>",
"    above), dysfunctional labor (see",
"    <a class=\"local\" href=\"#H16\">",
"     'Dysfunctional labor'",
"    </a>",
"    above), obstruction, and placental abruption (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Placental abruption'",
"    </a>",
"    above). However, most of these studies were biased in their selection of cases, so a causal association is unproven.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Postpartum hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have reported an increased risk of postpartum hemorrhage in pregnancies complicated by fibroids (unadjusted OR 1.8, 95% CI 1.4-2.2 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/38\">",
"     38",
"    </a>",
"    ]) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/2,40,54\">",
"     2,40,54",
"    </a>",
"    ], especially if the fibroids are large (&gt;3 cm) and located behind the placenta [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/10,21,23\">",
"     10,21,23",
"    </a>",
"    ] or the delivery is by cesarean [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/54\">",
"     54",
"    </a>",
"    ]. Numerous other studies have found no association between fibroids and postpartum hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/8,39,46\">",
"     8,39,46",
"    </a>",
"    ]. Pathophysiologically, fibroids could predispose to postpartum hemorrhage by decreasing both the force and coordination of uterine contractions, thereby leading to uterine atony [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Fetal demise",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rates of intrauterine fetal demise are not increased in pregnancies complicated by uterine fibroids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/37,47\">",
"     37,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Pain management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Five to 15 percent of women with fibroids will require hospitalization at some point during their pregnancy for pain management [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/3,23,39,54\">",
"     3,23,39,54",
"    </a>",
"    ]. We suggest supportive care and administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    as a preliminary intervention.",
"   </p>",
"   <p>",
"    Narcotic analgesia, or a course of nonsteroidal anti-inflammatory drugs (NSAID), can be employed when pain is not controlled by these measures [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/18,20\">",
"     18,20",
"    </a>",
"    ]. One regimen is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    25 mg orally every six hours for up to 48 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/20\">",
"     20",
"    </a>",
"    ]. Therapy should be limited to pregnancies at less than 32 weeks of gestation because of the possibility of premature closure of the ductus arteriosus, neonatal pulmonary hypertension, oligohydramnios, and",
"    <span class=\"nowrap\">",
"     fetal/neonatal",
"    </span>",
"    platelet dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/20,58-60\">",
"     20,58-60",
"    </a>",
"    ]. If indomethacin is continued for greater than 48 hours, weekly sonographic assessment for oligohydramnios and narrowing of the fetal ductus arteriosis should be performed. If either of these findings is noted, indomethacin should either be discontinued or reduced to 25 mg every 12 hours. Repeat courses can be given as needed for recurrent episodes of pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35674?source=see_link&amp;anchor=H1279823#H1279823\">",
"     \"Inhibition of acute preterm labor\", section on 'Cyclooxygenase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Myomectomy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1086340629\">",
"    <span class=\"h3\">",
"     Preconception myomectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are inadequate data on which to base decisions about the risks and benefits of preconception myomectomy for prevention of fibroid associated complications in pregnancy. As discussed above, large fibroids that are either submucosal or retroplacental in location are more likely to be associated with pregnancy complications. However, it is impossible to predict which fibroids will grow in pregnancy or where the placenta will implant. As such, we suggest that the decision as to whether to recommend prophylactic myomectomy be individualized with specific attention made to the patient's age and past reproductive history, as well as the size and location of her fibroids.",
"   </p>",
"   <p>",
"    Preconception myomectomy might improve the likelihood of a successful pregnancy in women with recurrent pregnancy loss, especially when no other identifiable etiology for the previous spontaneous abortions can be found [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/1,61\">",
"     1,61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26679?source=see_link\">",
"     \"Evaluation of couples with recurrent pregnancy loss\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1086340637\">",
"    <span class=\"h3\">",
"     Antepartum myomectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy has generally been regarded as a contraindication to myomectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/9\">",
"     9",
"    </a>",
"    ]. However, several case series have suggested that myomectomy can be safely performed in the first and second trimesters of pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/1,3,19,21,46,62-67\">",
"     1,3,19,21,46,62-67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common indication for myomectomy in pregnancy is intractable fibroid pain. In one of the largest series, 106 pregnant women with uterine fibroids were enrolled in a clinical protocol for operative or conservative management of fibroids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/67\">",
"     67",
"    </a>",
"    ]. Surgical intervention was pursued in patients with recurrent pain, a rapidly growing fibroid (defined as doubling in size over eight weeks), or a fibroid &gt;5 cm located in the lower uterine segment or deforming the placental site. According to these criteria, 18 patients underwent myomectomy and 88 were managed conservatively. No spontaneous abortions occurred in the surgical group, while the conservatively managed group had a 13.6 percent",
"    <span class=\"nowrap\">",
"     (12/88)",
"    </span>",
"    spontaneous abortion rate. The rate of preterm birth was lower in the surgical group (5.6 versus 22.7 percent, respectively), but the cesarean delivery rate was higher (93.7 percent versus 34 percent). No patient who had a myomectomy underwent puerperal hysterectomy, while 4.5 percent of conservatively managed patients underwent this procedure. Fetal outcomes were good in both groups. There was one perinatal death in a patient who declined to enter the surgical arm of the trial and ultimately delivered at 32 weeks of gestation. Despite this report, we believe every effort should be made to avoid antepartum myomectomy until further data are available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H348912443\">",
"    <span class=\"h3\">",
"     Cervical and prolapsed fibroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical fibroids and submucosal fibroids that have prolapsed through the cervix are rare during pregnancy. A pedunculated fibroid on a thin stalk can be removed if it is causing excessive bleeding or pain, infected, or interfering with vaginal delivery or urinary flow [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. In other cases, conservative management until the puerperium is warranted because intervention may lead to hemorrhage, rupture of membranes, pregnancy loss, and need for hysterectomy. Cesarean delivery is usually required for large, nonpedunculated cervical fibroids obstructing the birth canal [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/70\">",
"     70",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The origin of the fibroid can usually be determined by transvaginal ultrasound. Magnetic resonance imaging may be used as a second line imaging modality if additional information is clinically necessary, such as when antepartum or intrapartum removal is being considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1086340659\">",
"    <span class=\"h3\">",
"     Intrapartum myomectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only definitive indication for myomectomy at the time of cesarean delivery is if the presence of the fibroid makes it impossible to adequately close the uterine incision. Performing an elective myomectomy at the time of cesarean delivery is typically discouraged due to the increased risk of hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/65\">",
"     65",
"    </a>",
"    ]. This risk is significantly greater at term than in the first or second trimesters of pregnancy. In the first trimester, the uterus receives only 2 to 3 percent of the cardiac output. At term, however, the uterus receives in excess of 17 percent of the cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The high risk of hemorrhage is illustrated by the following series. In a case series of nine patients who underwent myomectomy at the time of cesarean delivery, three (33 percent) were complicated by severe hemorrhage requiring puerperal hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/3\">",
"     3",
"    </a>",
"    ]. In another report of 25 myomectomies performed at the time of cesarean delivery, five patients (20 percent) received blood transfusions, although none required hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/71\">",
"     71",
"    </a>",
"    ]. A similar study of 13 intrapartum myomectomies reported that one case (8 percent) was complicated by severe hemorrhage requiring blood transfusion and uterine artery ligation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/1\">",
"     1",
"    </a>",
"    ]. More favorable results have been reported with removal of pedunculated fibroids at the time of cesarean delivery. In a series of five myomectomies performed during cesarean, the four pedunculated fibroids were removed without difficulty while removal of the single nonpedunculated fibroid was associated with severe hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/54\">",
"     54",
"    </a>",
"    ]. We feel the decision to proceed with elective myomectomy at the time of cesarean delivery should be approached with caution and should probably be limited only to patients with symptomatic pedunculated fibroids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Cesarean delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;We maintain third trimester hemoglobin levels above 9.5 to 10",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    in women at high risk of intrapartum or postpartum hemorrhage at the time of cesarean delivery, such as women with large, retroplacental or anterior lower uterine segment fibroids. Iron supplementation is usually adequate therapy Erythropoietin is an option for patients who do not respond to iron supplements, and blood transfusion is a last resort for those who are refractory to medical therapy.",
"   </p>",
"   <p>",
"    A vertical skin incision and a posterior or classical hysterotomy are often necessary to obtain adequate exposure if the fibroids are located in the lower uterine segment. Every effort should be made to avoid cutting through fibroids as it can be impossible to close the hysterotomy site if the fibroids are in it. In situations where performing intrapartum myomectomy is likely unavoidable, we suggest blood products",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a cell saver be readily available and consideration be given to preoperative placement of bilateral iliac artery balloon catheters.",
"   </p>",
"   <p>",
"    A pilot study suggested that uterine artery ligation at the time of cesarean delivery may be associated with increased shrinkage of uterine fibroids postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/72\">",
"     72",
"    </a>",
"    ], but further clinical studies and",
"    <span class=\"nowrap\">",
"     risk/benefit",
"    </span>",
"    analyses are needed before such an intervention can be recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Management of patients with prior myomectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;While uterine rupture during labor in patients with prior myomectomy has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/73\">",
"     73",
"    </a>",
"    ], the magnitude of this risk is more difficult to ascertain. One study estimated that uterine rupture occurred in 1 of 40 pregnancies in which an abdominal myomectomy had been performed [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/74\">",
"     74",
"    </a>",
"    ]. Another study reported no uterine ruptures in 120 patients who had underwent abdominal myomectomy; however, this cohort was limited to myomectomies that did not enter the uterine cavity and were not complicated by postoperative infection [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/75\">",
"     75",
"    </a>",
"    ]. A study by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network observed no uterine ruptures in 176 women who reported a prior myomectomy and subsequently delivered vaginally or by cesarean, but the authors did not review operative reports so the type and extent of myomectomy surgery were unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other reports have suggested the risk of uterine rupture and dehiscence following laparoscopic myomectomy is higher than after open myomectomy due to the technical challenge of laparoscopic suturing [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/77,78\">",
"     77,78",
"    </a>",
"    ]. Moreover, such uterine ruptures may occur in the third trimester prior to the onset of labor [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. Despite these concerns, the 9 studies describing results of pregnancy following laparoscopic myomectomy reported only 1 uterine rupture in 211 deliveries [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the absence of strong evidence about rupture risk on which to base a recommendation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/81\">",
"     81",
"    </a>",
"    ], we take a conservative approach and suggest cesarean delivery prior to the onset of labor if the myometrium was significantly compromised (eg, uterine cavity was entered or nearly entered during a prior myomectomy, a large number of myomas were removed). The American College of Obstetricians and Gynecologists (ACOG) suggests delivery at",
"    <span class=\"nowrap\">",
"     37",
"     <sup>",
"      0/7ths",
"     </sup>",
"    </span>",
"    to",
"    <span class=\"nowrap\">",
"     38",
"     <sup>",
"      6/7ths",
"     </sup>",
"    </span>",
"    weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/82\">",
"     82",
"    </a>",
"    ]. We suggest assessing fetal pulmonary maturity by amniocentesis at 36 to 37 weeks with planned cesarean delivery if mature. If the patient does not wish to undergo amniocentesis, we recommend cesarean delivery at 38 weeks of gestation without assessing fetal pulmonary maturity. In cases where the myometrium was not significantly compromised, we suggest the patient be managed similar to women who have had a prior cesarean delivery, including continuous fetal monitoring in labor, early access to obstetric anesthesia, and labor in units equipped to perform an emergent cesarean delivery should it become necessary. An exception to this is if the patient had a pedunculated fibroid removed, which would not be expected to compromise the integrity of the myometrium. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5290?source=see_link\">",
"     \"Choosing the route of delivery after cesarean birth\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another concern at the time of delivery is the possible association between a prior hysteroscopic removal of a submucosal fibroid and abnormal placentation, especially placenta accreta [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/83\">",
"     83",
"    </a>",
"    ]. Although the risk of placenta accreta after prior myomectomy appears to be low [",
"    <a class=\"abstract\" href=\"UTD.htm?14/45/15065/abstract/76\">",
"     76",
"    </a>",
"    ], data are sparse and we suggest ultrasound screening for possible placenta accreta in the second and third trimester. &nbsp;",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/7/8311?source=see_link\">",
"     \"Clinical features and diagnosis of placenta accreta, increta, and percreta\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most fibroids do not exhibit a significant change in volume during pregnancy; those that do increase in size tend to do so primarily in the first trimester. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Change in size during pregnancy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Large (at least 3 cm) submucosal and retroplacental fibroids that distort the uterine cavity may be associated with adverse pregnancy events, including pain, vaginal bleeding, placental abruption, fetal growth restriction, and preterm labor and birth. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest symptomatic treatment of pregnancy complications related to fibroids (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Every effort should be made to avoid surgical removal of fibroids in pregnancy because of the risk of significant morbidity (hemorrhage). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest elective cesarean delivery prior to the onset of labor if the uterine cavity was entered during a prior myomectomy or a large number of myomas were removed (eg, greater than 6) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In the absence of these criteria, we suggest patients with a prior myomectomy be managed similar to women who have had a prior cesarean delivery (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Management of patients with prior myomectomy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/1\">",
"      Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981; 36:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/2\">",
"      Qidwai GI, Caughey AB, Jacoby AF. Obstetric outcomes in women with sonographically identified uterine leiomyomata. Obstet Gynecol 2006; 107:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/3\">",
"      Exacoust&ograve;s C, Rosati P. Ultrasound diagnosis of uterine myomas and complications in pregnancy. Obstet Gynecol 1993; 82:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/4\">",
"      Strobelt N, Ghidini A, Cavallone M, et al. Natural history of uterine leiomyomas in pregnancy. J Ultrasound Med 1994; 13:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/5\">",
"      Laughlin SK, Baird DD, Savitz DA, et al. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol 2009; 113:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/6\">",
"      Stout MJ, Odibo AO, Graseck AS, et al. Leiomyomas at routine second-trimester ultrasound examination and adverse obstetric outcomes. Obstet Gynecol 2010; 116:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/7\">",
"      Terry KL, De Vivo I, Hankinson SE, Missmer SA. Reproductive characteristics and risk of uterine leiomyomata. Fertil Steril 2010; 94:2703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/8\">",
"      Lev-Toaff AS, Coleman BG, Arger PH, et al. Leiomyomas in pregnancy: sonographic study. Radiology 1987; 164:375.",
"     </a>",
"    </li>",
"    <li>",
"     Cunningham, FG, Leveno, KJ, Bloom, SL, et al. Williams Obstetrics, 22nd ed, McGraw-Hill, New York 2005. p. 962.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/10\">",
"      Muram D, Gillieson M, Walters JH. Myomas of the uterus in pregnancy: ultrasonographic follow-up. Am J Obstet Gynecol 1980; 138:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/11\">",
"      Winer-Muram HT, Muram D, Gillieson MS, et al. Uterine myomas in pregnancy. Can Med Assoc J 1983; 128:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/12\">",
"      Aharoni A, Reiter A, Golan D, et al. Patterns of growth of uterine leiomyomas during pregnancy. A prospective longitudinal study. Br J Obstet Gynaecol 1988; 95:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/13\">",
"      Rosati P, Exacoust&ograve;s C, Mancuso S. Longitudinal evaluation of uterine myoma growth during pregnancy. A sonographic study. J Ultrasound Med 1992; 11:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/14\">",
"      Neiger R, Sonek JD, Croom CS, Ventolini G. Pregnancy-related changes in the size of uterine leiomyomas. J Reprod Med 2006; 51:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/15\">",
"      De Vivo A, Mancuso A, Giacobbe A, et al. Uterine myomas during pregnancy: a longitudinal sonographic study. Ultrasound Obstet Gynecol 2011; 37:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/16\">",
"      Laughlin SK, Hartmann KE, Baird DD. Postpartum factors and natural fibroid regression. Am J Obstet Gynecol 2011; 204:496.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/17\">",
"      Lynch, FW. Fibroid tumors complicating pregnancy and labor. Am J Obstet 1913; 68:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/18\">",
"      Rice JP, Kay HH, Mahony BS. The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol 1989; 160:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/19\">",
"      Katz VL, Dotters DJ, Droegemeuller W. Complications of uterine leiomyomas in pregnancy. Obstet Gynecol 1989; 73:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/20\">",
"      Dildy GA 3rd, Moise KJ Jr, Smith LG Jr, et al. Indomethacin for the treatment of symptomatic leiomyoma uteri during pregnancy. Am J Perinatol 1992; 9:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/21\">",
"      De Carolis S, Fatigante G, Ferrazzani S, et al. Uterine myomectomy in pregnant women. Fetal Diagn Ther 2001; 16:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/22\">",
"      Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 2007; 87:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/23\">",
"      Phelan JP. Myomas and pregnancy. Obstet Gynecol Clin North Am 1995; 22:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/24\">",
"      Monga AK, Woodhouse CR, Stanton SL. Pregnancy and fibroids causing simultaneous urinary retention and ureteric obstruction. Br J Urol 1996; 77:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/25\">",
"      Feusner AH, Mueller PD. Incarceration of a gravid fibroid uterus. Ann Emerg Med 1997; 30:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/26\">",
"      Courban D, Blank S, Harris MA, et al. Acute renal failure in the first trimester resulting from uterine leiomyomas. Am J Obstet Gynecol 1997; 177:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/27\">",
"      Lee WL, Chiu LM, Wang PH, et al. Fever of unknown origin in the puerperium. A case report. J Reprod Med 1998; 43:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/28\">",
"      Nguyen QH, Gruenewald SM. Sonographic appearance of a postpartum pyomyoma with gas production. J Clin Ultrasound 2008; 36:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/29\">",
"      Laubach M, Breugelmans M, Leyder M, et al. Nonsurgical treatment of pyomyoma in the postpartum period. Surg Infect (Larchmt) 2011; 12:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/30\">",
"      Mason TC, Adair J, Lee YC. Postpartum pyomyoma. J Natl Med Assoc 2005; 97:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/31\">",
"      Kobayashi F, Kondoh E, Hamanishi J, et al. Pyomayoma during pregnancy: a case report and review of the literature. J Obstet Gynaecol Res 2013; 39:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/32\">",
"      Lin YH, Hwang JL, Huang LW, Chen HJ. Pyomyoma after a cesarean section. Acta Obstet Gynecol Scand 2002; 81:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/33\">",
"      Benson CB, Chow JS, Chang-Lee W, et al. Outcome of pregnancies in women with uterine leiomyomas identified by sonography in the first trimester. J Clin Ultrasound 2001; 29:261.",
"     </a>",
"    </li>",
"    <li>",
"     Gabbe, SG, Niebyl, JR, Simpson, JL. Obstetrics: Normal and problem pregnancies, 4th ed, Churchill Livingstone, Pennsylvania 2002. p. 739.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/35\">",
"      Wallach EE, Vu KK. Myomata uteri and infertility. Obstet Gynecol Clin North Am 1995; 22:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/36\">",
"      Blum M. Comparative study of serum CAP activity during pregnancy in malformed and normal uterus. J Perinat Med 1978; 6:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/37\">",
"      Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol 2000; 95:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/38\">",
"      Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol 2008; 198:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/39\">",
"      Roberts WE, Fulp KS, Morrison JC, Martin JN Jr. The impact of leiomyomas on pregnancy. Aust N Z J Obstet Gynaecol 1999; 39:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/40\">",
"      Winer-Muram HT, Muram D, Gillieson MS. Uterine myomas in pregnancy. J Can Assoc Radiol 1984; 35:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/41\">",
"      Sheiner E, Bashiri A, Levy A, et al. Obstetric characteristics and perinatal outcome of pregnancies with uterine leiomyomas. J Reprod Med 2004; 49:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/42\">",
"      Chen YH, Lin HC, Chen SF, Lin HC. Increased risk of preterm births among women with uterine leiomyoma: a nationwide population-based study. Hum Reprod 2009; 24:3049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/43\">",
"      Lai J, Caughey AB, Qidwai GI, Jacoby AF. Neonatal outcomes in women with sonographically identified uterine leiomyomata. J Matern Fetal Neonatal Med 2012; 25:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/44\">",
"      Shavell VI, Thakur M, Sawant A, et al. Adverse obstetric outcomes associated with sonographically identified large uterine fibroids. Fertil Steril 2012; 97:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/45\">",
"      Davis JL, Ray-Mazumder S, Hobel CJ, et al. Uterine leiomyomas in pregnancy: a prospective study. Obstet Gynecol 1990; 75:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/46\">",
"      Vergani P, Ghidini A, Strobelt N, et al. Do uterine leiomyomas influence pregnancy outcome? Am J Perinatol 1994; 11:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/47\">",
"      Koike T, Minakami H, Kosuge S, et al. Uterine leiomyoma in pregnancy: its influence on obstetric performance. J Obstet Gynaecol Res 1999; 25:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/48\">",
"      Forssman L. Distribution of blood flow in myomatous uteri as measured by locally injected 133Xenon. Acta Obstet Gynecol Scand 1976; 55:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/49\">",
"      Graham JM, Miller ME, Stephan MJ, Smith DW. Limb reduction anomalies and early in utero limb compression. J Pediatr 1980; 96:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/50\">",
"      Romero R, Chervenak FA, DeVore G, et al. Fetal head deformation and congenital torticollis associated with a uterine tumor. Am J Obstet Gynecol 1981; 141:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/51\">",
"      Matsunaga E, Shiota K. Ectopic pregnancy and myoma uteri: teratogenic effects and maternal characteristics. Teratology 1980; 21:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/52\">",
"      Heinonen PK, Saarikoski S, Pystynen P. Reproductive performance of women with uterine anomalies. An evaluation of 182 cases. Acta Obstet Gynecol Scand 1982; 61:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/53\">",
"      Worthen NJ, Gonzalez F. Septate uterus: sonographic diagnosis and obstetric complications. Obstet Gynecol 1984; 64:34S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/54\">",
"      Hasan F, Arumugam K, Sivanesaratnam V. Uterine leiomyomata in pregnancy. Int J Gynaecol Obstet 1991; 34:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/55\">",
"      Szamatowicz J, Laudanski T, Bulkszas B, Akerlund M. Fibromyomas and uterine contractions. Acta Obstet Gynecol Scand 1997; 76:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/56\">",
"      Sheiner E, Biderman-Madar T, Katz M, et al. Higher rates of tachysystole among patients with clinically apparent uterine leiomyomas. Am J Obstet Gynecol 2004; 191:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/57\">",
"      Vergani P, Locatelli A, Ghidini A, et al. Large uterine leiomyomata and risk of cesarean delivery. Obstet Gynecol 2007; 109:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/58\">",
"      Niebyl JR, Witter FR. Neonatal outcome after indomethacin treatment for preterm labor. Am J Obstet Gynecol 1986; 155:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/59\">",
"      Moise KJ Jr. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. Am J Obstet Gynecol 1993; 168:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/60\">",
"      Vermillion ST, Scardo JA, Lashus AG, Wiles HB. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 1997; 177:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/61\">",
"      Li TC, Mortimer R, Cooke ID. Myomectomy: a retrospective study to examine reproductive performance before and after surgery. Hum Reprod 1999; 14:1735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/62\">",
"      Febo G, Tessarolo M, Leo L, et al. Surgical management of leiomyomata in pregnancy. Clin Exp Obstet Gynecol 1997; 24:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/63\">",
"      Wittich AC, Salminen ER, Yancey MK, Markenson GR. Myomectomy during early pregnancy. Mil Med 2000; 165:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/64\">",
"      Celik C, Acar A, Ci&ccedil;ek N, et al. Can myomectomy be performed during pregnancy? Gynecol Obstet Invest 2002; 53:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/65\">",
"      Michalas SP, Oreopoulou FV, Papageorgiou JS. Myomectomy during pregnancy and caesarean section. Hum Reprod 1995; 10:1869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/66\">",
"      Glavind K, Palvio DH, Lauritsen JG. Uterine myoma in pregnancy. Acta Obstet Gynecol Scand 1990; 69:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/67\">",
"      Mollica G, Pittini L, Minganti E, et al. Elective uterine myomectomy in pregnant women. Clin Exp Obstet Gynecol 1996; 23:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/68\">",
"      Straub HL, Chohan L, Kilpatrick CC. Cervical and prolapsed submucosal leiomyomas complicating pregnancy. Obstet Gynecol Surv 2010; 65:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/69\">",
"      Kilpatrick CC, Adler MT, Chohan L. Vaginal myomectomy in pregnancy: a report of two cases. South Med J 2010; 103:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/70\">",
"      Tian J, Hu W. Cervical leiomyomas in pregnancy: Report of 17 cases. Aust N Z J Obstet Gynaecol 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/71\">",
"      Ehigiegba AE, Ande AB, Ojobo SI. Myomectomy during cesarean section. Int J Gynaecol Obstet 2001; 75:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/72\">",
"      Liu WM, Wang PH, Tang WL, et al. Uterine artery ligation for treatment of pregnant women with uterine leiomyomas who are undergoing cesarean section. Fertil Steril 2006; 86:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/73\">",
"      Miller CE. Myomectomy. Comparison of open and laparoscopic techniques. Obstet Gynecol Clin North Am 2000; 27:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/74\">",
"      Georgakopoulos PA, Bersis G. Sigmoido-uterine rupture in pregnancy after multiple myomectomy. Int Surg 1981; 66:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/75\">",
"      BROWN AB, CHAMBERLAIN R, TE LINDE RW. Myomectomy. Am J Obstet Gynecol 1956; 71:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/76\">",
"      Gyamfi-Bannerman C, Gilbert S, Landon MB, et al. Risk of uterine rupture and placenta accreta with prior uterine surgery outside of the lower segment. Obstet Gynecol 2012; 120:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/77\">",
"      Nezhat C. The \"cons\" of laparoscopic myomectomy in women who may reproduce in the future. Int J Fertil Menopausal Stud 1996; 41:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/78\">",
"      Matsunaga JS, Daly CB, Bochner CJ, Agnew CL. Repair of uterine dehiscence with continuation of pregnancy. Obstet Gynecol 2004; 104:1211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/79\">",
"      Grande N, Catalano GF, Ferrari S, Marana R. Spontaneous uterine rupture at 27 weeks of pregnancy after laparoscopic myomectomy. J Minim Invasive Gynecol 2005; 12:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/80\">",
"      Dubuisso JB, Fauconnier A, Babaki-Fard K, Chapron C. Laparoscopic myomectomy: a current view. Hum Reprod Update 2000; 6:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/81\">",
"      Spong CY, Mercer BM, D'alton M, et al. Timing of indicated late-preterm and early-term birth. Obstet Gynecol 2011; 118:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/82\">",
"      American College of Obstetricians and Gynecologists. Committee Opinion No. 560. Medically indicated late-preterm and early-term deliveries. Obstet Gynecol 2013; 121:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/45/15065/abstract/83\">",
"      Levine D, Hulka CA, Ludmir J, et al. Placenta accreta: evaluation with color Doppler US, power Doppler US, and MR imaging. Radiology 1997; 205:773.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6801 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-197.136.42.3-3C221AEBB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15065=[""].join("\n");
var outline_f14_45_15065=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CHANGE IN SIZE DURING PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3541764\">",
"      Fibroid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3695835\">",
"      - Pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3541975\">",
"      - Other complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3541780\">",
"      Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Pregnancy loss",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Antepartum bleeding",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Preterm labor and birth",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Preterm premature rupture of membranes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Placental abruption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Placenta previa",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Preeclampsia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Fetal growth restriction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Fetal anomalies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Malpresentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Dysfunctional labor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Cesarean delivery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Postpartum hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Fetal demise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Pain management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Myomectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1086340629\">",
"      - Preconception myomectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1086340637\">",
"      - Antepartum myomectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H348912443\">",
"      - Cervical and prolapsed fibroids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1086340659\">",
"      - Intrapartum myomectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Cesarean delivery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Management of patients with prior myomectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5290?source=related_link\">",
"      Choosing the route of delivery after cesarean birth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/7/8311?source=related_link\">",
"      Clinical features and diagnosis of placenta accreta, increta, and percreta",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26679?source=related_link\">",
"      Evaluation of couples with recurrent pregnancy loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35674?source=related_link\">",
"      Inhibition of acute preterm labor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/14/18666?source=related_link\">",
"      Overview of treatment of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/40/32393?source=related_link\">",
"      Pathogenesis of spontaneous preterm birth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/0/6153?source=related_link\">",
"      Physiology of parturition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/60/30662?source=related_link\">",
"      Reproductive issues in women with uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_45_15066="Abnormal placentation in preeclampsia";
var content_f14_45_15066=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 619px\">",
"   <div class=\"ttl\">",
"    Abnormal placentation in preeclampsia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 599px; height: 558px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Exchange of oxygen, nutrients, and waste products between the fetus and mother depends on adequate placental perfusion by maternal vessels. In normal placental development, invasive cytotrophoblasts of fetal origin invade the maternal spiral arteries, transforming them from small-caliber resistance vessels to high-caliber capacitance vessels capable of providing placental perfusion adequate to sustain the growing fetus. During the process of vascular invasion, the cytotrophoblasts differentiate from an epithelial phenotype to an endothelial phenotype, a process referred to as \"pseudovasculogenesis\" or \"vascular mimicry\" (Upper panel). In preeclampsia, cytotrophoblasts fail to adopt an invasive endothelial phenotype. Instead, invasion of the spiral arteries is shallow and they remain small caliber, resistance vessels (Lower panel).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 2005; 46:1077. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15066=[""].join("\n");
var outline_f14_45_15066=null;
var title_f14_45_15067="Sendai criteria for pancreatic resection";
var content_f14_45_15067=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F53511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F53511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Sendai criteria for pancreatic resection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Size",
"       </td>",
"       <td class=\"subtitle1\">",
"        Management",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;3 cm",
"       </td>",
"       <td>",
"        Always resect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"6\">",
"        &lt;3 cm",
"       </td>",
"       <td>",
"        Resect if:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Patient is symptomatic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mural nodules are present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Main pancreatic duct is dilated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Common bile duct dilation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Peripancreatic adenopathy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Guidelines for resection of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6:17.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15067=[""].join("\n");
var outline_f14_45_15067=null;
var title_f14_45_15068="Surgical therapy of acute type A aortic dissection";
var content_f14_45_15068=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77273&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77273&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    European Society of Cardiology guidelines: surgical therapy of acute type A aortic dissection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Recommendation",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Class",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Emergency surgery to avoid tamponade/aortic rupture.",
"       </td>",
"       <td>",
"        I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Valve-preserving surgery; tubular graft if normal sized aortic root and no pathological changes of valve cusps.",
"       </td>",
"       <td>",
"        I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Replacement of aorta and aortic valve (composite graft) if ectatic proximal aorta and/or pathological changes of valve/aortic wall.",
"       </td>",
"       <td>",
"        I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Valve-sparing operations with aortic root remodelling for abnormal valves.",
"       </td>",
"       <td>",
"        IIa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Valve preservation and aortic root remodelling in Marfan patients.",
"       </td>",
"       <td>",
"        IIa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"        Classification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class I:",
"        </strong>",
"        Conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class II:",
"        </strong>",
"        Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class IIa:",
"        </strong>",
"        Weight of evidence/opinion is in favor of usefulness/efficacy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class IIb:",
"        </strong>",
"        Usefulness/efficacy less well established by evidence/opinion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class III:",
"        </strong>",
"        Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful and in some cases may be harmful.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data reproduced with permission from Erbel, R, Alfonso, F, Boileau, C, et al, Eur Heart J 2001; 22:1642.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15068=[""].join("\n");
var outline_f14_45_15068=null;
var title_f14_45_15069="Stroke risk in carotid stenosis";
var content_f14_45_15069=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F60048&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F60048&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Severity of carotid stenosis predicts stroke risk",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 383px; height: 280px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Relation between the degree of carotid artery stenosis and the annual risk of stroke.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Barnett, HJ, Eliasziw, M, Meldrum, HE, Taylor, DW, Neurology 1996; 46:603.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15069=[""].join("\n");
var outline_f14_45_15069=null;
var title_f14_45_15070="Contents: Nonmelanoma skin cancer and related disorders";
var content_f14_45_15070=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Nonmelanoma skin cancer and related disorders",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Nonmelanoma skin cancer and related disorders",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Actinic keratosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/49/18200\">",
"           Epidemiology, natural history, and diagnosis of actinic keratosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/15/30968\">",
"           Treatment of actinic keratosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Basal cell carcinoma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/39/14970\">",
"           Epidemiology and clinical features of basal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/45/15063\">",
"           Evaluation for locoregional and distant metastases in cutaneous squamous cell and basal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/5/44121\">",
"           Nevoid basal cell carcinoma syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/61/14293\">",
"           Systemic treatment of advanced cutaneous squamous and basal cell carcinomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/23/13690\">",
"           Treatment and prognosis of basal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/8/24712\">",
"           Treatment of basal cell carcinomas at high risk for recurrence",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Keratoacanthoma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/63/4090\">",
"           Keratoacanthoma: Epidemiology, risk factors, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/3/24632\">",
"           Keratoacanthoma: Management and prognosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Merkel cell carcinoma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/35/6712\">",
"           Clinical features and diagnosis of Merkel cell (neuroendocrine) carcinoma and sebaceous cell carcinoma of the skin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/31/3577\">",
"           Staging and treatment of Merkel cell carcinoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Microcystic adnexal carcinoma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/61/33752\">",
"           Microcystic adnexal carcinoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Organ transplant recipients",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/60/37832\">",
"           Epidemiology and risk factors for skin cancer in solid organ transplant recipients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/8/2186\">",
"           Management of skin cancer in solid organ transplant recipients",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Porokeratosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/44/4810\">",
"           Porokeratosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Squamous cell carcinoma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/11/7351\">",
"           Clinical features and diagnosis of cutaneous squamous cell carcinoma (SCC)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/56/25482\">",
"           Epidemiology and risk factors for cutaneous squamous cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/45/15063\">",
"           Evaluation for locoregional and distant metastases in cutaneous squamous cell and basal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/46/21226\">",
"           Recognition and management of high-risk (aggressive) cutaneous squamous cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/61/14293\">",
"           Systemic treatment of advanced cutaneous squamous and basal cell carcinomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/30/31209\">",
"           Treatment and prognosis of cutaneous squamous cell carcinoma",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-3D28A2602E-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f14_45_15070=[""].join("\n");
var outline_f14_45_15070=null;
var title_f14_45_15071="Left atrial thrombus AF Echo";
var content_f14_45_15071=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81863&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81863&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left atrial thrombus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 249px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transesophageal echocardiogram showing a thrombus (T) in the left atrial appendage (LAA) in a patient with atrial fibrillation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Warren Manning, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_45_15071=[""].join("\n");
var outline_f14_45_15071=null;
